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ABSTRACT
Human herpesviruses are ubiquitous pathogens worldwide with 90% of the global
population infected with one or more Human herpesviruses (HHV’s) by adulthood. All
herpesviruses have three unique life cycle stages. Upon resolution of a primary acute stage
infection, they can establish a latent stage infection within the host cell nucleus. This stage
is characterized primarily by transcriptional quiescence of the viral genome. Specific
physiological conditions (e.g., cell stress) can cause the latent virus to enter the reactivation
stage, often many years after resolution of the acute infection, in which the virus becomes
replicationally active again. HHV’s are known to cause disease in humans in all three
stages of their lifecycle and chronic infection is becoming increasingly associated with a
wide range of human morbidities. The field has been met with challenges in establishing
tractable cell models to study HHV infection in vitro and the exact mechanisms regulating
the maintenance of, and transition between, the life cycle stages are largely undefined;
however, chromatin structure and function are known to play a role. In this dissertation I
employ both molecular and computational approaches to study the higher order chromatin
structures and chromatin states in cell models of infection for two Human herpesviruses at
specific stages in their life cycles.
In the first part of this dissertation, I successfully demonstrate the establishment of
a latent Human betaherpesvirus 6A (HHV-6A) infection, which requires integration of its
genome into the host cell genome, in an in vitro-derived HEK-293 cell model. I then
employ unbiased epigenomic methods along with bioinformatics techniques to identify
three-dimensional virus-host contact regions and characterize the chromatin states of the
latent virus. I then demonstrate the above in both a patient-derived cell model and in
infected primary cells. Finally, I developed a novel and innovative computational approach
to identify the sites of HHV-6A integration in host cell chromosomes using next generation
sequencing data: to my knowledge, a first in the field.
In the second part of this work, I employ a human fetal lung fibroblast (HFL) cell
model of acute infection to study Varicella Zoster Virus (VZV) chromatin biology specifically with regards to the transcription factor CTCF. CTCF is a key organizer of
chromatin three-dimensional structure and plays a role in chromatin organization and
transcriptional regulation in certain HHV’s. Herein, I present evidence that CTCF is likely
involved in virus-host structural interactions – an important finding that is countervailing
to the current suppositions of the Human alphaherpesvirus field.
Overall, the work presented herein offers novel insight into the complex and
dynamic relationship between HHV’s and host cell chromatin. With a more comprehensive
characterization of the higher order chromatin structures and chromatin states that define
this relationship, we can better define the HHV life cycle. Such knowledge will allow for
the development of improved treatments against these insidious infections.
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CHAPTER 1

Human herpesviruses

Human herpesviruses are ubiquitous pathogens with greater than 90% of the world
population having one or more herpesviruses by adulthood (Lan and Luo, 2017). All
Human herpesviruses (HHVs) were originally referred to as herpesviruses hominis (Lusso
et al., 2007) (Bastian et al., 1972) and as simplex by 1973 (Baringer and Swoveland, 1973).
At that time Varicella Zoster Virus, or VZV, was not known to be the in the same family
as herpes simplex and was not known to be the same pathogen that causes shingles or
herpes zoster (HZ): ‘Although varicella and HZ were known to be related, it was not until
1965 that the British general practitioner, Dr Robert E. Hope-Simpson, suggested that
“herpes zoster is a spontaneous manifestation of varicella infection ”.’ (Hope-Simpson,
1964) (Depledge et al., 2018b). Thus, it was only in the 1960s that the capacity for
herpesviruses to remain dormant in their hosts subsequent to initial infection , and become
transcriptionally competent again at a future timepoint, was discovered.
These different “states” of HHV infection are now referred to as stages of the HHV
life cycle which are characterized by periods of differential transcriptional and replicational
activity. There are three stages to the life cycle: acute, latent, and reactivation, and this
ability to transition to different life cycle stages is the most defining characteristic of all
herpesviruses, even those not endemic to humans (Wang et al., 2020). The ability to
establish a latent infection is related to the very etymology of the word “herpes”, which is
1

derived from the classical Greek verb “herpein”, meaning “to creep”. The “creeping”
nature of this virus is evidenced by its ability to evade the host cell immune response during
the latent stage of its life cycle (De Bolle et al., 2005). To achieve this ability to hide during
latency, HHVs have evolved to take up residence in the nucleus of a variety of human
tissue types and have evolved impressive mechanisms to avoid the host immune system,
leading to their pervasive presence across the globe.

Health effects acute and chronic

HHVs cause a wide range of health issues in humans including genital lesions,
chicken pox, shingles, encephalitis, cerebrovascular disease and even cancer. Most of the
readily visible manifestations of HHV infection are found during the acute and reactivation
stages of the virus life cycle. The Human alphaherpesviruses HSV-1 and HSV-2 are the
primary causes of cold sores and genital herpes, while VZV is the cause of chickenpox.
Approximately 90% of all adults harbor the latent HHV-6 virus - primarily spread via
saliva, and the initial infection usually occurs between 6 months and 2 years of age. The
human betaherpesvirus HHV-6B is the primary cause of febrile seizures in otherwise
healthy children and is the causative agent of roseola infantum (exanthema subitem or
Sixth’s disease). Both HHV-6A and HHV-6B primary infection can lead to viral
encephalitis in both children and adults – an oftentimes serious medical condition (Mullins
and Krishnamurthy, 2020) (Gewurz et al., 2008) as well as thyroiditis (Seyyedi et al.,
2019). Additionally, HHV-6A and B are now known to greatly increase the likelihood and
severity of developing acute graft-versus-host-disease (aGVHD) in transplant recipient
2

patients. aGVHD is a serious medical condition that can lead to multi-systemic organ
failure (Gotoh et al., 2014; Agut et al., 2017). Furthermore, approximately 1% of the
world’s population harbors a germline integrated form of the virus - iciHHV-6, resulting
in these individuals harboring a copy of the HHV-6 genome in every cell in their body
(Collin and Flamand, 2017). Thus, individuals with this condition are at a much greater
risk for developing morbidities such as post-transplant complications. HHV-7 infection
generally presents with few if any symptoms but is also associated with roseola and
encephalitis - particularly in immune compromised individuals (Wolz et al., 2012). The
Human gammaherpesviruses Epstein-Barr Virus (EBV) is the causative agent of
mononucleosis or “mono” (Dunmire et al., 2015), while human cytomegalovirus (HCMV)
can lead to health complications in immunocompromised individuals as well (Britt, 2008).
Kaposi Sarcoma-associated Herpesvirus (KSHV or HHV-8) generally does not cause
disease in healthy (non-immunocompromised) individuals during the acute and replication
stages of infection, but as its name implies, it does cause Kaposi sarcoma in some
individuals,

particularly

in

those

that

are

immunocompromised

(Dupin).

Gammaherpesviruses such as EBV also been known to contribute to periodontal disease as
well (Binshabaib et al., 2018).
While the health complications arising from the acute and replication stages of
HHV infections are fairly well characterized at this point, the long term, chronic health
effects of latent and reactivating infection are less well characterized overall. In some cases,
such as infection with the human gammaherpesviruses EBV and KSHV, the low grade
chronic expression of the latent stage viral transcripts are known now to be oncogenic in
humans, particularly in immunocompromised individuals - the only two HHVs known to
3

be oncogenic (De Bolle et al., 2005; Luo and Ou, 2015; Goncalves et al., 2017; Song et al.,
2019). VZV, the causative agent of chickenpox, or varicella, can reactivate years or
decades later to cause shingles (Arvin, 1996; Sauerbrei). In fact, about one third of all
patients with VZV will get shingles in their lifetime, sometimes with neurological sequelae
(Depledge et al., 2018b). Additionally, the long terms effects of all the Human
alphaherpesviruses: HSV-1, HSV-2, and VZV, the primary neurotrophic HHVs, are
increasingly being associated with neurological complications such as Alzheimer’s disease
(Mancuso et al., 2019) and cerebrovascular disease (Nagel and Bubak, 2018). Overall,
numerous studies in recent years have begun to associate chronic HHV infection with a
wide range of human diseases ranging from cardiovascular disease, and stroke, to neurodegenerative disorders and autoimmune disease.

HHV virology

As discussed above, HHVs are associated with disease at all stages of their life
cycle and can lead to both acute and long-term health complications. While much of the
biology surrounding the external causes of transition between life cycle stages, as well as
the exact mechanisms governing these dynamic transitions are still under investigation,
many aspects of HHV virology, fortunately, are well understood at this point. In fact, the
viral transcriptional landscapes of HHVs are among the best characterized of the doublestranded DNA viruses (Alba et al., 2001). Many HHV genomes have been fully sequenced
to date, and this genetic and molecular information has allowed taxonomists to accurately
classify HHVs together in the family Herpesviridae and subsequently into three subfamilies
4

based on their gene content, cellular tropism and genome organization (Alba et al., 2001).
In addition to their more common clinical names, which vary for historical reasons, the
international committee on the taxonomy and nomenclature of viruses (ICTV) employs a
genus-species-number naming system, e.g., Human herpesvirus 1-8 (HHV-1 – HHV-8) for
purposes of the standardization of nomenclature. The exception in naming with regards to
HHVs is HHV-6A/B, which, as of 2012, was officially reclassified from a single HHV-6
virus into two separate Human betaherpesviruses: HHV-6A and HHV-6B (Adams and
Carstens, 2012). Furthermore, HHVs are placed into the Double-stranded DNA viruses of
the Baltimore classification of viruses.
Based on the above information, Human herpesviruses are now known to represent
a distinct group of the herpesvirus family, comprising nine species across three sub families
(alpha, beta, and gamma). The three sub-families are thought to have diverged over 200
million years ago, before mammalian speciation (Aswad et al., 2020) and infected a wide
variety of animal genera, but restricted groups of species within each taxon (Aswad et al.,
2020) (McGeoch et al., 1995). Thus, these viruses have evolved along with pre-human
primates, then humans, for millions of years.
There are important similarities and differences in terms of structure and function
between individual HHV species as well. Structurally, all HHVs share a great deal of
similarity. They are all large, double-stranded DNA viruses. The average length of a
herpesvirus genome is approximately 130kbp and the average diameter of a herpesvirus
virion is around 200nm. The double-stranded genetic material is contained within a viral
capsid displaying pleiomorphic icosahedral (T-20) symmetry. All herpesviruses also
contain a structural tegument layer of viral-encoded proteins and RNAs that sit between
5

the nucleo-capsid and the outer viral membrane. This tegument has shown to be ordered
and important to herpesvirus virion assembly and host-cell egress. The outer viral envelope
contains glycoproteins that maculate the surface of the virion and are responsible for host
cell identification and binding (Guo et al., 2010).
All HHVs typically have between 70 and 120 open reading frames (ORFs), which
have become synonymous with viral genes, that encode hundreds of potential gene
products (Alba et al., 2001). All HHVs contain a set of core genes, a subset of sub-family
specific genes, and a variable number of ORFs unique to the individual virus (Alba et al.,
2001). While new virus genes are still being discovered, many of the core proteins
regulating the initial stages of acute infection as well as many of the genes that are
expressed solely during latency have been identified, and homology does exist across these
identified genes (Arvey et al., 2012). In terms of key differences between the HHV species,
it is the unique ORF’s mentioned above that allow the individual HHV species to operate
within their own specific ecological niches.
As discussed above, both the many commonalities and distinctly unique elements
of the individual HHVs have enabled the successful taxonomic classification of these
viruses, and much of the epidemiology and pathophysiology of HHV infection has been
uncovered. Above all, the presence of the distinct life cycle stages is perhaps the single
most defining and uniting characteristic of all HHVs. However, the specific mechanisms
that regulate the maintenance of, and transition between, the different life cycle stages, both
within and across individual HHVs, still remains largely a mystery. For example, while it
is currently understood that HHVs are known to reactivate from their latent life cycle stages
(regaining transcriptional and replicational competency) under certain physiological
6

stressors such as hormonal imbalances (De Bolle et al., 2005), the precise cellular
mechanisms governing the reactivation of latent HHVs, as well as those governing the
acute to latent transition, have yet to be uncovered. However, because herpesviruses are
nuclear-only replicating DNA viruses, host cell chromatin biology was initially suspected,
and has since been confirmed, to play a role in regulating the HHV life cycle.
Early studies with the Human gammaherpesviruses EBV as well as with the human
alphaherpesvirus HSV-1 were among the first to demonstrate the role that host cell
chromatin plays in the HHV life cycle. Human gammaherpesviruses were chosen because
their preferred cell tropism for replication are actively dividing CD8+ and CD4+ T cells
(Long et al., 2019). Furthermore, EBV was well known to the public as the causative agent
of mononucleosis and has been found to be oncogenic (Yin et al., 2019). Thus, the facts
that they infect regularly dividing cells, along with their public presence and carcinogenic
potential, put them at the forefront of research. The alphaherpesviruses HSV-1 (and HSV2 and VZV) were also early contenders for the development of models to study the HHV
life cycle, as cold sores, genital herpes, chickenpox, and shingles are well known to the
public. In addition, there were early successes in the establishment of animal models of
infection with HSV-1 and successful reproduction of components of human disease in
these models (Webre et al., 2012). In contrast, the study of betaherpesviruses lagged that
of the other HHVs, largely due to their more recent discovery and formerly unknown role
in disease etiology. Furthermore, it is puzzling on the surface why the cellular study of
VZV infection, the HHV in which the presence of life cycle stages was first confirmed, has
not been at the forefront of HHV chromatin biology research . This is largely due to two
factors. Firstly, researchers were not able to establish and reactivate infection in small
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animal models like they were with HSV-1, and secondly, the biology of VZV has lent itself
to the successful creation of vaccines (Eshleman et al., 2011). For a discussion of why the
development of a VZV vaccine has been successful compared to other herpesviruses
(particularly vs. HSV-1) see Rouse et al. (Rouse and Kaistha, 2006).
To summarize, EBV is arguably the HHV about which the most chromatin biology
is currently understood, followed in second place by HSV-1. In fact, these two viruses have
been so well established relative to other HHVs, it is often within the contextual framework
of their respective chromatin biology that hypotheses for other HHVs, such as HHV-6A
and VZV – which are focus of this dissertation, are developed, tested, and compared
against. Furthermore, the betaherpesviruses are somewhat unique in terms of their
chromatin biology in that HHV-6A/B and possibly HHV-7 (Prusty et al.) require
integration of their genome into the host cell genome to establish latency. The site of
integration is generally the subtelomeric regions near the ends of host chromosomes,
regions that have been difficult to assay due to their repetitive nature (Aimola et al., 2020).
Regardless of the popularity of specific HHVs within the chromatin research world,
all herpesviruses are nucleus-only replicating DNA viruses, and their biology is closely
intertwined with that of the host cell nucleus. As host chromatin structure and function, as
well as cell and viral factors, have been demonstrated to work in concert to control
transcription and replication in HHVs (such as EBV and HSV-1), it therefore follows that
a basic understanding of the chromatin biology of both the host and virus, as well as of the
cell models and experimental methodology employed to uncover said biology, is essential
to gaining clear understanding of the complex dynamics of the HHV life cycle.
8

Chromatin biology of the host

As mentioned above, HHVs are nuclear-only replicating viruses, with transcription
replication, and encapsidation, all occurring predominantly within the nucleus of the
infected host cell (Heming et al., 2017). Organization of host DNA within the human cell
nucleus is organized into chromatin. Chromatin is comprised of concatenations of
nucleosomes, each nucleosome itself being comprised of DNA wrapped 1.46 times around
an octamer of core histone proteins. This core octamer is in turn composed of two copies
each of histone proteins H2A, H2B, H3, and H4. The core nucleosome is also bound by
the H1 histone protein via a 46 bp length of DNA. In total, the core-plus-linker histone
protein complex is wrapped approximately two times by a total of 200bp of DNA. Each
nucleosome is in turn connected via the DNA strand to other nucleosomes in a chain-like
fashion. This linear chain of nucleosomes is then wrapped and folded into a higher order
structure called the 30nm fiber (Hubner et al., 2013). These fibers and the threedimensional conformations that they can assume within the nucleus are referred to in this
work as higher order chromatin structures.
This higher order structuring allows the human genome, which is approximately
one meter in length, to fit within a human cell nucleus (approximately seven µm in
diameter). In addition, alteration of post-translational modification of the tails of histone
proteins allows for structural loosening and tightening of the chromatin into open/loose or
closed/compact regions. This regulation of compaction in turn allows for the regulation of
access of the DNA to transcriptional machinery (Conn and Schang, 2013). These posttranslational modifications of the amino-terminal tail of the histone proteins also provide
9

docking sites for proteins and contribute to the structural stability of the three-dimensional
chromatin conformation (Conn et al., 2013).
In addition to the compactness of the host chromatin the three-dimensional structure
of chromatin is highly organized within the larger nuclear architectural framework. The
three-dimensional structure of the nucleus is partitioned into topologically associating
domains or TADs. Genomic regions within a TADs are more likely to in teract with each
other than with regions in other TADs. Thus, this partitioning leads to three-dimensional
conformational organization within the host cell nucleus that comprises the higher order
chromatin structures of the genome. The adoption of such conformational states adds
another level at which the cell can regulate transcription of its genome (Beagan and
Phillips-Cremins, 2020).
While chromatin structure itself an important aspect of genomic regulation. A
variety of chromatin accessory factors such as histone modifying enzymes, transcription
factors, and members of transcriptional regulating protein complexes play a role in
regulating the level of compactness and the three-dimensional orientation of the host cell
chromatin. The regions of the genome that encode for or regulate the above elements
(promoters, enhancers, repetitive regions etc.) are referred to, within a spatial context, as
chromatin states (Ernst and Kellis, 2015). Taken together, the higher order chromatin
structures, chromatin states, and chromatin accessory factors all work together to regulate
the host cellular genome.

10

The transcription factor CTCF

With a brief review of host (human) chromatin now complete, special attention will
be paid to the transcription factor CTCF. CTCF is a ubiquitous transcription factor encoded
by the CTCF gene, also referred to as CCCTC-binding factor. It contains 11-zinc finger
motifs for binding to DNA and performs many roles in the cell. While transcriptionally, it
generally acts as a repressor (Filippova et al., 1996), it also plays a key role as an organizer
of chromatin architecture/conformation (Phillips and Corces, 2009). It achieves this ability
via serving as a structural linking, or anchoring, protein between the cohesin protein
complex and chromatin (Rubio et al., 2008). To exert its transcriptional repressive effects,
CTCF acts as a transcriptional insulator. It sterically prevents specific regions of DNA from
spatially interacting with other each other. For example, CTCF can sterically prevent an
enhancer region of the genome from reaching its regulatory target. Besides its chromatin
organizing and transcriptional regulatory roles, CTCF is even involved in VDJ
recombination in the immune system, where it organizes the formation of chromatin loops
to effect the chromatin conformational changes necessary for VDJ recombination in B and
T-cells (Chaumeil and Skok, 2012).
CTCF clearly plays many important roles in organizing and regulating the host cell
genome, but it has also been found to be heavily involved in the chromatin biology of
HHVs as well. As will be discussed in more detail further in this chapter, Human
gammaherpesviruses, such as EBV, are known to utilize CTCF to tether their own genomes
to the host cell genome – an essential feature for the establishment and maintenance of the
latent life cycle stage in these viruses, as well as for the coordination of viral replication
11

during the acute and reactivation stages of infection. In addition, both EBV and HSV-1
have been found to harbor CTCF binding regions across their respective genomes, and
utilize CTCF to regulate genomic transcription, much in the same way that the uninfected
host cell does. Thus, CTCF is an important factor in both host and virus chromatin biology.

Genomics methodology

As chromatin has been demonstrated to play a role in the dynamic life cycle of
HHV, methods used to assay host cell chromatin biology can be employed within the
context of HHV infection. Because the host nucleus is a dynamic and complexly structured
organelle, a lot of information must be simultaneously evaluated when seeking to
comprehensively interrogate nuclear structure and function. The development of genomic
methodologies in recent years have become powerful tools in addressing this challenge.
These methods can capture a great deal of structural and functional information regarding
the biological system under investigation. Some methods lend themselves to elucidating
genome or transcriptome sequence information without consideration of chromatin
structures or accessory factors with which the genome or transcriptome may be interacting
at the time of experiment. Other methods, conversely, are less concerned with sequence
information and seek to capture information concerning chromatin structure, including,
histone modifications and three-dimensional structure, or seek to capture the effects of
particular chromatin remodeling enzymes or identify the presence and/or distribution of
particular transcription factors as they interact with the host cell genome. Currently, it is
12

becoming more common to employ multiple techniques simultaneously to capture
information about various aspects of the host cell chromatin biology across different
treatment conditions and timepoints. Such combinational approaches are allowing
researchers to investigate how chromatin structural organization and interactions with
cellular factors work together to dynamically regulate the genome. Each method possesses
its own strengths and weaknesses and must be considered for dispatch within the context
of the goals of the experiment and the hypotheses under consideration (Kempfer and
Pombo, 2020).
To capture transcriptomic information, RNA-sequencing allow the researcher to
access far greater quantities of genetic and transcriptomic information more efficiently and
more comprehensively than the earlier molecular biology techniques that preceded them.
The entire mRNA of a sample of cells can be extracted, converted, to cDNA libraries and
undergo the same sequencing processes used for DNA sequencing. This provides an
unbiased method for quantification of transcripts from which sequence alteration
information and differential splicing abundance can be identified and quantified. More
recently, single-cell RNA sequencing allows researchers to assay the transcriptomes of
heterogenous cell populations to look at transcriptional differences arising between
individual cells (Goodwin et al., 2016).
While sequencing data lends itself to addressing a variety of hypotheses, regarding
questions pertaining to chromatin biology specifically, other powerful genomics methods
have been developed to interrogate the state of chromatin conformation and higher order
chromatin structure as well as the association of transcription factors and chromatin
remodeling enzymes with the host cell chromatin.
13

Chromatin immuno-precipitation sequencing, or ChIP-Seq, allows researchers to
pull down chromatin associating factors using antibodies specific for them. Antibodies are
created against the DNA-binding factors and unbound regions of the DNA are not
extracted. These antibodies are then isolated from the digested cellular material and
unlinked form the DNA-to which they are bound. This DNA can then undergo highthroughput sequencing, as mentioned earlier, to gain insight as to the quantity and
distribution of specific DNA and chromatin associated factors, such as transcription
factors, under specific experimental conditions (Beagan et al., 2020). In fact, ChIP-seq can
be performed sequentially with antibodies to proteins that are hypothesized to be
complexed together. This so-called “ChIP-ReChIP” provides the researcher insight into
host factors that may be associating together, such as two members of a protein complex
that may be working in concert.
With ChIP-Seq, the DNA region under investigation must be contained within
chromatin that is sterically open enough (in a euchromatic state) to allow the DNA-binding
factor of interest to “land” on the DNA sequence to which it normally binds. However,
depending on the hypothesis, it can also be informative to identify regions of the genome
that are contained within compact heterochromatin where such transcription factors would
have difficulty binding due to steric restrictions. These regions are said to be in a
heterochromatic state or “chromatinized”. In such a case, we can turn to digestion methods
such as MNase-Seq or ATAC-Seq to assess which regions of the genome under
investigation are contained within open or closed chromatin (Beagan et al., 2020).
To identify closed or heterochromatic regions, MNase sequencing uses micrococcal
nuclease to digest all DNA within the host genome that is not bound to histone proteins.
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After digestion, the chromatin histone proteins are unlinked from the DNA to which they
are attached, and the DNA can be isolated and undergo sequencing. Conversely, ATAC
sequencing can be applied to uncover regions that are not bound to histone proteins and
can give insight into which regions of the genome under investigation are contained within
euchromatin and are thus more likely to be transcriptionally active (Beagan et al., 2020).
While MNase-Seq and ATAC-Seq are useful for gaining insight into regions of the
genome that are contained in open or closed chromatin, they do not provide spatial or threedimensional conformational information about the chromatin. To assay the threedimensional chromatin conformation or higher order chromatin structures within a cell
nucleus, we turn to the “C” family of genomics methodologies. The “C’s” usually refer to
either chromatin or conformation or both. These techniques aim to capture information
about the three-dimensional chromatin structure of the nucleus under investigation. Higher
order chromatin structural information is important because phenomena like DNA-looping
are known to be involved with transcriptional regulation and the organization of the
genome into the three-dimensional segmented compartments that define TADs, which also
contribute to the overall regulation of the cellular genome (Beagan et al., 2020).
The first “C” methodology to be developed was “3C-Seq”, which stands for
chromosome conformation capture sequencing. In 3C-Seq, a primer is designed for a
specific region of interest in the host cell genome. This region is usually referred to as a
bait. A primer is defined for two regions of interest that are suspected of interacting, or
contacting, one another, spatially. The primers anneal to the region(s) of interest and are
crosslinked with a protein that protects this region of interest from enzymatic digestion.
The protected region can then be de-protected (generally a de-crosslinking procedure) and
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the researcher is left with a region of the genome with which this region was interacting
(Beagan et al., 2020).
The second “C’ method in the lineup is chromosome conformation capture circular
sequencing or 4C-Seq. In this case, the cells are fixed (generally with paraformaldehyde)
and then subject to multiple rounds of nuclease digestion, enzymatic ligation and
decrosslinking, that ultimately result in circular DNA amplicons of genetic regions that
were in spatial proximity to each other at the time of fixation. Primers are made for a
specific region of interest and will anneal to the specific amplicons that contain their hybrid
sequence. The hybrid amplicons then undergo PCR elongation and amplification before
being sent for sequencing (Krijger et al., 2020). Ultimately, the researcher obtains DNA
sequences that can undergo computational alignment to a reference genome in order to
identify the regions of the host genome under investigation to which the bait, or viewpoint,
primer region was proximal in three-dimensional space. Thus, 4CSeq provides a snapshot
of the higher order chromatin conformation of the sample genome in the vicinity of the
viewpoint region at the time of fixation. As a final note, 4C-Seq lends itself particularly
well to investigating the higher order structural interactions between small exogenous
chromosomes, such as an infecting HHV genome, with the host cell genome. Because the
HHV genome is so small relative to the human genome, 4C-Seq results for a small number
of viral viewpoint regions can identify virus-host interactions for much a viral genome.
Building on the 4C-Seq framework, 5C can use an array of bait or viewpoint
primers to get spatial information for multiple regions simultaneously and HiC will digest
the entire genome into fragments to find interacting regions across an entire genome. In
the case of HiC over 5C, one will gain additional breadth of genomic information (i.e., the
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entire genome) at the cost of some specificity of the identified interactions (Beagan et al.,
2020). Taken together, the “C” family of technologies are powerful tools for identifying
higher-order spatial genomic interactions and providing information about the higher order
chromatin conformation of the nuclei being investigated.
There are many variations of the above genomics methodologies and new
permutations and iterations seem to appear almost daily at times. The various alterations
to the main methods described above are generally implemented in order to evaluate a
biological hypothesis under very specific experimental conditions. Furthermore, these
techniques can be combined with any number of other molecular biology techniques providing a level of experimental customization tailored to the needs of the researchers’
goals. But at their core, these methods all aim to allow researchers to answer specific
questions about the chromatin states, higher-order interactions, and association between
chromatin and DNA-binding factors and chromatin remodeling enzymes, that dynamically
work together to regulate chromatin organization and the transcription of the cell genome.
With a brief overview of both the host cell chromatin biology and current state of genomics
methodologies complete, I will now review the literature surrounding the HHV chromatin
biology that is germane to the main body of work presented in chapters 2 and 3.

Human gammaherpesviruses and host chromatin (EBV)

Most of what initially became known about the role of chromatin in Human
herpesviruses began with studies of Human gammaherpesviruses, particularly the wellcharacterized oncogenic virus EBV using LCLs, or human lymphoblastoid cell lines
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(Arvey et al., 2012). These cell lines are commonly employed as cell models in
gammaherpesvirus studies, and they are created via infection of primary human Blymphocytes with EBV (Neitzel, 1986; Hussain and Mulherkar, 2012). The genetically
stable, proliferating cell lines contain multicopy episomal EBV genomes that then persist
across cell divisions. Specific factors, that will be discussed more in the next section, can
be added to reactivate the latent virus after it has transitioned from an acute to a latent
infection (Chau et al., 2006; Wang et al., 2006).
With the establishment of these competent cell models, the early chromatin studies
of EBV focused on assaying the virus and host genomes for specific transcriptionally
activating (H3K27ac, H3K4me3) or repressive (H3K9me3, H3K27me3) histone marks or
for chromatin factors such as CTCF that were known to play key roles on chromatin
organization in healthy cells. Active EBV genes during acute infection were found to
contain nucleosome-free promoter regions, demonstrating not only that host chromatin
plays a role in regulating the HHV life cycle but that acute infection appeared to be
associated with open, euchromatin regions of the genome (Zhou et al., 2005). It was not
long before it was discovered that specific histone modifications are associated with
different cell cycle stages and that chromatin boundary factors such as CTCF were
identified as key contributors to the latent stage of the EBV life cycle (Arvey et al., 2012).
In addition, besides its chromatin organizing functionality, CTCF was found to act
as a chromatin insulator in EBV - where it serves as a barrier to the transcription of
particular EBV genes (Amelio et al., 2006; Arvey et al., 2012; Pentland and Parish, 2015).
It has since been identified as the key insulator in Human gammaherpesviruses that
18

separates or “insulates” distinct temporal transcription clusters from one another (Tempera
et al., 2010; Arvey et al., 2012).
These spatially separated viral gene clusters that are expressed at temporally
distinct periods are referred to as comprising a particular “kinetic class” and are found in
all the HHVs. Although, they typically are defined solely for the acute stage infection. But
with EBV (and potentially HSV-1), disparate kinetic classes for the latent life cycle stage
have also been identified and have been deemed “latency programs” (Arvey et al., 2012).
These different latency programs have been identified within different cell types, giving
rise to the delineation of “sub-stages” within the latent stage of EBV. To add to the
complexity, in addition to viral proteins, miRNAs, ncRNAs and snoRNAs have been found
to be expressed as part of these acute and latent expression profiles (Hutzinger et al., 2009;
Arvey et al., 2012).
Thus, kinetic clusters comprise a variety of gene products, and it is not just CTCF
insulator activity that is associated with their transcriptional regulation. Histone
modifications have been found to be enriched at clusters of microRNAs (miRNAs) and
non-coding RNAs in EBV as well, indicating that other chromatin factors besides CTCF
likely play a role in regulating these RNAs. Potentially, these non -coding RNAs could
themselves play a role in regulating the HHV life cycle (Arvey et al., 2012).
While CTCF has been shown to be a chromatin organizer and transcriptional
insulator, perhaps its most important role in EBV infection was the discovery that CTCF
binds with cohesin protein to form a CTCF-cohesin protein complex that allows the EBV
genome to tether itself to the host genome during both an active acute (lytic) infection, and
also during latency (Arvey et al., 2012). This tethering is a defining characteristic of latency
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in gammaherpesviruses and underlines the critical importance of CTCF to the regulation
of the gammaherpesvirus life cycle (it was also identified in KSHV). To date,
Gammaherpesvirus researchers have been able to fully characterize how the cohesin
complex, containing CTCF, regulates the three-dimensional conformation of the EBV
virus episome (Arvey et al., 2012).
In addition to the CTCF-mediated higher order chromatin structure, the histone
modifications and transcription factor binding sites that comprise the chromatin states of
the EBV infection have been well-characterized as well. One study found that 26 of 60
total surveyed transcription factors had 109 bindings sites across the entire EBV genome.
These binding sites were found to be arranged in clusters along the virus genome. Such
clusters are likely regulatory hotspots and are found in other model organisms as well
(Gerstein et al., 2010), and have been identified in HSV-1 (Amelio et al., 2006). Thus, EBV
likely utilizes a variety of host cell gene products to coordinate its own life cycle.
Overall, HHV genomes are dense and contain numerous overlapping ORFs.
Additionally, the identification of alternative donor and acceptor splice sites led to the
discover of numerous alternatively spliced viral genes in EBV. Alternative spliceoforms
could potentially contribute to modulation of the virus life cycle via chromatin involvement
as well.
Overall, our understanding of the expression profiles that largely define the HHV
life cycle have only become more complex in recent years, as have the number of ways
that chromatin could be interacting with the viral genome to regulate its life cycle. The first
full systems biology approach to the study of HHV chromatin and life cycle was by Arvey
et al., in 2012, which involved multiple simultaneous genomic experiments, along with the
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incorporation of publicly available DNA, and this study paved the way for the
incorporation of systems genomics methods in the herpes virology field (Arvey et al.,
2012). Such studies are rapidly improving the resolution at which the boundaries between
(and within) the EBV life cycle are being defined. EBV studies have led the way in the
uncovering the role of chromatin biology in the HHV life cycle and it remains the HHV in
which we have the clearest understanding of the mechanisms governing the dynamic HHV
life cycle. But another HHV has also provided researchers with an enormous wealth of
information pertaining to HHV chromatin biology.

Human alphaherpesviruses and host chromatin (HSV-1)

The human gammaherpesviruses, particularly EVB, remains the HHV about which
we know the most chromatin biology, but a great deal is known about the role of chromatin
during HSV-1 (herpes simplex 1 or human alphaherpesvirus 1) infection as well. As was
seen above with EBV, the HSV-1 life cycle appears to be regulated by a complex interplay
of chromatin structures, chromatin states, and other host and virus factors.
While the chromatin biology is not as well understood as that of EBV, quite a bit is
known relative to other HHVs. HSV-1 researchers have benefitted from the fact that many
in vivo cell types and animal models have been successfully employed in the study of this
virus, whereas the same cannot be said of another alphaherpesvirus, VZV, about which my
work is covered in chapter 3 of this dissertation.
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MNase studies have found that host chromatin associates with viral HSV-1 genes
at all stages of infection and this finding was found to be independent of DNA replication
status (Cliffe and Knipe, 2008; Conn et al., 2008; 2011; 2013; Cabral et al., 2018). It has
been shown that chromatin regulates nuclear DNA accessibility through mechanisms such
as remodeling enzymes that can control heterochromatin state, nucleosome stability, and/or
recruitment of transcription factors (Hu et al., 2019). Such chromatin regulation in fact
plays a major role in the normal host DNA repair, DNA replication, and DNA transcription
processes (Turner, 2000; Berger, 2002; Cosgrove et al., 2004; Henikoff and Grosveld,
2008; Hu et al., 2019). Further evidence in recent years has increasingly emphasized the
dynamic role that chromatin biology plays in the acute and latent (as well as reactivated)
stages of the HSV-1 life cycle.
As with EBV acute, infection, viral gene expression proceeds in a temporal fashion
defined by the sequential expression of different kinetic classes of genes (as all HHVs are
believed to follow). For DNA replication to occur, “IE” or “immediate early” proteins must
initiate expression of “E” or “early” proteins that must be expressed. After competent
replication has begun, L or “late” genes are only then transcribed (Tombacz et al., 2017a).
The initial virion protein, which is found in the tegument, called virion protein 16
or VP16, is the first and foremost activating viral protein involved in transcription of the
immediate-early (hereafter IE) HSV-1 genes. The IE proteins such as ICP0 and ICP4 then
go on to recruit chromatin remodelers, along with transcription activators, to their
respective promoter regions. The subsequent recruitment of said remodelers by ICP0 and
ICP4 then leads to transcription of the early and late viral genes. Intracellular viral DNA,
isolated with EdU-labeling and click chemistry, has been shown to associate with VP16,
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ICP4, and ICP22 (Dembowski and DeLuca, 2015). Emphasizing the role of potential
feedback mechanisms in the early stages of acute HSV-1 infections. It is known that VP16
can initiate HSV-1 viral transcription by recruiting both methyltransferases and
demethylases, as well as histone acetylases (Herrera and Triezenberg, 2004; Kristie et al.,
2010; Vogel and Kristie, 2013; Lang et al., 2017). Furthermore, VP16 recruits histone
acetyl transferases (HATs) to HSV-1 associated chromatin. These HATs include
CBP/p300, GCN5, and PCF (Memedula and Belmont, 2003; Wysocka and Herr, 2003;
Herrera and Triezenberg, 2004), but interestingly, they have been shown via knockdown
to not have a strong overall effect on transcription (Kutluay et al., 2009; Kutluay and
Triezenberg, 2009).
Following activation by VP16, ICP4 will then recruit chromatin remodelers to the
HSV-1 genome (Kalamvoki and Roizman, 2011; Wagner and DeLuca, 2013) which then
induces histone dynamics (Gibeault et al., 2016) to activate the early (E) and late (L) genes
(Gu and DeLuca, 1994). In turn, ICPO, enhances immediate early (IE), early (E) and late
(L) gene expression. ICP0 also induces degradation of specific cellular factors which then
leads to the silencing of histone variants. This silencing in turn alters histone occupancy
(Lomonte et al., 2001; Lomonte and Morency, 2007; Cliffe and Knipe, 2008; Ferenczy and
DeLuca, 2009; 2011). In terms of chromatin and transcription activators, ICP0 blocks
histone deacetylation. It performs this feat through interactions with the REST/Co-REST
complexes (Gu et al., 2005; Poon et al., 2006; Cliffe and Knipe, 2008; Coleman et al.,
2008; Ferenczy and DeLuca, 2009) as well as interacting with chromatin remodelers.
Furthermore, ICP0 (an E3-ubiquitin ligase) can cause histone silencing proteins to be
degraded. Examples of such variants include Cenp-A and Cenp-B (Lomonte et al., 2001;
23

Lomonte and Morency, 2007). Additionally, previous studies have shown that ICP4 will
increase chromatin dynamics of all the core histones as well as interact with chromatin
remodelers (such as the CLOCK complex) (Conn et al., 2008; 2011; Kalamvoki and
Roizman, 2011; Conn et al., 2013; Gibeault et al., 2016). Overall, the role of chromatin in
the initial stages of HSV-1 acute infection is a complex and dynamic process involving an
interplay of host chromatin structures, and chromatin states.
As mentioned earlier, HSV-1 is known to associate with host chromatin at all stages
of its life cycle and it has been found to be associated with silenced chromatin during
latency (Deshmane and Fraser, 1989; Wang et al., 2005; Cliffe et al., 2009; Bloom et al.,
2010). Mutations in ICP4, ICP0 and VP16 have led to transcriptional silencing in
fibroblasts (the hallmark of latency) (Conn and Schang, 2013). Both the acetylation, as
well as methylation, of HSV-1-bound chromatin have been found to occur in distinct
regions of the host cell nucleus to contribute to latency (Kennedy et al., 2015). In the part
of the nucleus where the virus is associated with permissive H3K9ac, H3K14ac, and
H3K4me2 actively transcribed HSV-1 DNA is seen (Kubat et al., 2004a; Kubat et al.,
2004b; Neumann et al., 2007; Knipe and Cliffe, 2008). H3K9me2, H3K9me3, and
H3K27me3 are the modifications found on nucleosomes of the promoters of virus genes
that are transcriptionally silent (Cliffe and Knipe, 2008; Knipe and Cliffe, 2008; Cliffe et
al., 2009). Such activating and permissive histone marks cause changes in the
conformational state of the host chromatin, further emphasizing the importance of
chromatin spatial conformation during HSV-1 infection.
As with EBV, various factors leading to cell stress can induce reactivation of latent
HSV-1. Hypoxia (Bloom et al., 2010), inhibition or alteration of the mTOR pathway
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(Kobayashi et al., 2012; Wilson and Mohr, 2012), odium butyrate (NaB), infected tissue
explanation (Ertel et al., 2012), and dexamethasone treatment (Du et al., 2012), can all
cause reactivation of cells infected with HSV-1. Thus, cellular pathways, epigenetic
modifications, chemical exposure, and changes in physiological environment have all been
found to contribute to the reactivation of latent HSV-1 virus (Kennedy et al., 2015).
As with EBV, CTCF is an important transcription factor that been found to play a
key role in regulating the HSV-1 life cycle. CTCF will bind many regions of the HSV-1
genome during the acute, latent, and reactivation stages (Lang et al., 2017). Concerning the
acute stage (lytic infection), previous ChIP-Seq experiments have shown that the CTCF
interacts extensively with the virus (Lang et al., 2017). When CTCF was knocked down
using CTCF siRNA in HeLa cells, a reduction in overall virus yield, virus genome copy
number, and a reduction of viral transcription was observed (Lang et al., 2017). In addition,
H3K9me3 and H3K27me3 deposition was increased on viral genes, and RNA Pol-II
deposition, was decreased following knockdown. RNA POL-II elongation was also found
to be facilitated by CTCF. This fact, along with the reduction in repressive chromatin
deposition associated with CTCF, demonstrates its role in promoting the transcription of
acute stage lytic viral genes. Furthermore, higher levels of RNA POL-II modified with
CTDSer2P was found relative to levels of the CTDSer5P modification (Lang et al., 2017),
indicating that differential POL-II phosphorylation, possibly regulated by CTCF, could
also impact the virus life cycle. Again, CTCF likely plays a crucial role in regulating the
HHV life cycle.
It has been shown that CTCF occupies specific DNA binding sites across the HSV1 genome, and earlier work had characterized the functionality of these sites as so -called
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“functional enhancer-blocking insulators”, essentially meaning that they acted as a
transcriptional roadblock - blocking enhancer DNA elements from reaching certain viral
gene promoter regions (Amelio et al., 2006; Washington et al., 2018). Furthermore, HSV1 evidenced CTCF eviction post-reactivation (Washington et al., 2018).
The above mentioned CTCF binding sites, or motifs, are conserved into clusters in
HSV-1. As with EBV, such clustering partitions the transcription profiles into different
domains (Amelio et al., 2006). Seven clusters of DNA binding motifs have been identified
from whole genome analysis of HSV-1 (Amelio et al., 2006) and were found to be
organized around each of the immediate early genes and found flanking the portion of the
latency-associated transcript (LAT) gene that is critical to latency and reactivation (Amelio
et al., 2006). Whether CTCF insulator activity first regulates transcriptional activity, or
whether it is transcriptional activity that first establishes CTCF insulator activity, remains
unclear (Hu et al., 2019). In mouse dorsal root ganglia (DRG) tissue, all seven of the CTCF
binding clusters were found to be occupied by CTCF during latency. Recombinant viruses
lacking IE transcription were used to demonstrate that IE expression evicts CTCF - upon
administration of a reactivation signal in these recombinant viruses there is no CTCF
eviction (Ertel et al., 2012). Thus, CTCF is shown to have a latency-maintaining role and
loss of CTCF is essential to the reactivation of HSV-1 in-vivo (Ertel et al., 2012). Finally,
CTCF is also able to interact with nuclear structures like lamin (Silva et al., 2008), and as
with EBV, CTCF-cohesin complexes were found to be responsible for the formation of
chromatin looping that regulates acute and latent transcription profiles (Kang et al., 2011;
Arope et al., 2013; Hansen et al., 2017; Schwartz et al., 2017).
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CTCF is again seen to play a critical role in regulating the higher order chromatin
structure in HSV-1 infection. Overall, the critical role of CTCF in the HSV-1 life cycle
must be emphasized. To recapitulate, CTCF is associated with nucleosome shifts,
delineates the euchromatic from heterochromatic viral genome regions, blocks enhancerdependent gene transcription, and complexes with cohesin protein to maintain DNA loops
(Amelio et al., 2006; Gaszner and Felsenfeld, 2006; Chen et al., 2007; Rubio et al., 2008).
Thus, as with EBV, we have mounting evidence that CTCF is critical to HSV-1 life cycle
dynamics and likely works in concert with a variety of host and viral structures and factors
to serve as the main chromatin switch in the regulation of the HHV life cycle.

Human betaherpesviruses and host chromatin (HHV-6A)

While the chromatin biology of the Human betaherpesviruses is not as developed
as that of the other HHVs, much has been discovered in recent years about the role of
chromatin in these viruses. Because T-cells are highly infectable by HHV-6A and because
CTCF is involved in VJD recombination (Chaumeil and Skok, 2012), there were initial
suspicions of a putative connection between CTCF and HHV-6 chromatin biology.
HHV-6A, along with HHV-6B, and possibly HHV-7, are unique among
herpesviruses in that they require the integration of their genome into the host genome to
establish latency and transcriptional quiescence. Thus, the chromatin biology surrounding
HHV-6A is expected to diverge somewhat from other HHVs. These, differences
notwithstanding, HHV-6A still shares many similarities with other viruses of its family.
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Like other HHVs, it is nucleus-only replicating virus and uses cytoplasmic organelles for
viral protein production and protein maturation (Naqvi et al., 2018). As with EBV and
HSV-1, the transcriptome of HHV-6A is turning out to be more complex than initially
thought. (Gompels et al., 1995; Dominguez et al., 1999; Gatherer et al., 2011; Gravel et al.,
2013; O'Grady et al., 2016; Balazs et al., 2017; Tombacz et al., 2017b; Balazs et al., 2018;
Depledge et al., 2019; Kara et al., 2019; O'Grady et al., 2019).
HHV-6A can infect a wide variety of cell types due to its ingress via the cell surface
receptor CD46 (De Bolle et al., 2005). But CD4+ T lymphocytes and particularly CD8+ T
cells are preferentially infected in vitro (Grivel et al., 2003). Other than T lymphocytes,
cells that have been successfully infected in vitro include natural killer cells,
oligodendrocytes, epithelial cells, astrocytes, fibroblasts, continuous liver cells, endothelial
cells, and embryonic kidney cells (Aimola et al.).
In vivo, it has been demonstrated that HHV-6A can infect brain tissue (Luppi et al.,
1994; Chan et al., 2001; Donati et al., 2003), liver tissue (Ozaki et al., 2001; Ishikawa et
al., 2002; Harma et al., 2003) tonsillar tissue (Roush et al., 2001) salivary glands (Fox et
al., 1990), and endothelium (Caruso et al., 2002). Bone marrow progenitors have been
found to harbor latent HHV-6, which may be transmitted longitudinally to differentiated
blood cells of different lineages (Luppi et al., 1999). This is confirmed by the
demonstration of HHV-6 in monocytes/macrophages (Kondo et al., 1991; Burd and
Carrigan, 1993; Kondo et al., 2002a) and dendritic cells (Kakimoto et al., 2002).
Patient-derived cells have become increasingly the subject of study as they provide
a physiologic environment like that of the in vivo infection. Lymphoblastoid cell lines or
LCLs are one such model that, as mentioned earlier, have been heavily used in the study
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of EBV, and they can be readily derived from patients’ cells and subsequently used to
model latent (and other) stages of the HHV-6A virus life cycle.
For the study of iciHHV-6A, which occurs in about 1 percent of the population, a
patient-derived iciHHV-6A cell line has been developed from the umbilical arteries of
patients with iciHHV-6A (Wallaschek et al., 2016). This patient-derived cell model thus
contains a cellular physiology that more closely emulates that of the in vivo physiology of
infection.
In addition to these patient-derived cell models, in vitro-derived cell models have
been developed. The best current in vitro model is a HEK293T cell model which contains
a recombinant HHV-6A genome (Uganda isolate 107 RefSeq id: NC_00164.4) with a
green fluorescent reporter protein (GFP) under transcriptional control of a human
cytomegalovirus (hCMV) promoter. The hCMV promoter is known to respond to specific
phorbol esters, such as TPA, that can be administered by the experimenter to reactivate the
virus after it has entered the transcriptionally quiescent latent stage of infection (Saviola et
al., 2019a). Thus, with this cell line – deemed ciHHV-6A, the experimenter has some
control over the HHV-6A life cycle stage.
When employing the above ciHHV-6A cell model, transcriptional activity is
evidenced during the acute lytic stage of infection via immunofluorescence microscopy,
which captures the GFP signal. As the virus proceeds to integrate its genome and enter
latency, over the course of its incubation period (~1-2 weeks), the attenuation of the GFP
signal can be seen to decrease over time, culminating in its complete abrogation with the
establishment of latent integration and the associated transcriptional quiescence that is the
hallmark of viral latency. Upon stimulation with the phorbol ester 12-O29

Tetradecanoylphorbol-13-acetate (TPA) the recrudescence of the GFP signal indicates a
return to transcriptional competency that defines the reactivated stage of the HHV life
cycle. RNA sequencing can also be performed over a time course to confirm the
establishment of latent infection in this cell model (Saviola et al., 2019a). Fluorescent in
situ hybridization, or FISH, has been used to identify integrated viral genomes within cell
models (Saviola et al., 2019a; Aimola et al., 2020; Aswad et al., 2020) and ChIP-Seq
experiments have been used to assay the chromatin deposition along the viral genome
during latent infection - demonstrating the enrichment of repressive histone marks (Saviola
et al., 2019a).
With cell models in place to study HHV-6A chromatin biology, it is important to
remember that integration is a defining characteristic of the HHV-6A life cycle.
Structurally, the genome is flanked by direct terminal repeat sequences or “DR” sequences.
Each direct repeat is approximately 8 kb in length and consists of two cleavage-packaging
motifs called pac-1 and pac-2. There are ORFs related to the direct repeats, ORF1 to ORF7
(in the traditional ORF numbering system). The most important feature of the terminal
direct repeats are their imperfect and perfect repeat arrays on the 5’ and 3’ ends of the viral
genome, respectively. The perfect repeat sequence on the 3’ end contains hexanucleotide
repeats that are identical to the canonical mammalian repeats (TTAGGG)n. This homology
is the feature that allows for the integration of the viral genome into the host genome via
homologous recombination. The recombination proceeds via either the base excision repair
pathway or the single strand annealing pathway. For a thorough review of HHV-6
integration see Aimola et al., 2020 (Aimola et al., 2020). Because HHV-6A has evolved to
exploit the chromatin region of the telomere, and because it is believed that the virus needs
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to excise itself to undergo competent transcription and replication, telomere chromatin
biology is hypothesized to play an important role in coordinating integration and
maintaining the stages of the HHV-6A life cycle. The virus has likely evolved to use the
higher order chromatin structure of the host to regulate its life cycle, while simultaneously
evading the host immune response. It has been further suggested (Aimola et al., 2020) that
the site of integration could be directly within the telomere loop that forms, along with
chaperone proteins, at the end cap of the human telomere. The nature of this t-loop, present
at the telomere ends, allows it to unravel during periods of chromatin restructuring, and the
virus could take advantage of this period to integrate itself (Aimola et al., 2020).
Looking to the future, researchers are still unclear as to the exact mechanisms, such
as the recruitment of the accessory enzymes necessary to procure integration, that lead to
homologous recombination of the infecting HHV-6A virus and the establishment of
latency. Fortunately, in the case of HHV-6A, cell models are available to study its
chromatin biology. I employ such cell models in the work that I outline in chapter 2 of this
dissertation. With that in mind, I will now move on to review the chromatin biology of
VZV.

VZV and host chromatin biology

Much more is known about HSV-1 chromatin biology within the alphaherpesvirus
subfamily than with its cousin VZV. HSV-1 has subsequently served as a hypothesisgenerating template of sorts for the investigation of VZV chromatin biology. Upon the
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resolution of an initial VZV infection, which typically presents as chickenpox, the virus
takes up residency exclusively in the dorsal root and cranial nerve (trigeminal nerve)
ganglia of the peripheral sensory nervous system. VZV is believed to enter ganglia via
retrograde axonal transport and hematogenous transport (Kennedy et al., 2015).
Like the other HHVs, the acute stage of the viral infection proceeds with the
sequential expression of viral genes by kinetic class: alpha, gamma, and beta (not to be
confused with the subfamily designations of the HHV taxonomic nomenclature). Like
other HHVs, almost all of the viral expression takes place in the host cell nucleus and so
again, host cell chromatin is heavily implicated in regulating the transcriptional profiles
that define the VZV life cycle stages. But as mentioned earlier, much less is understood
about the role of chromatin in the regulation of these life cycle stages, due to difficulty in
establishing successful animal and cell models that could capture the full spectrum of
infection, but also because VZV is the only HHV for which a vaccine exists, somewhat
mitigating the exigency for a more thorough understanding of the cellular biology of the
virus.
Unlike HSV-1, VZV reactivation is more prevalent in the elderly and tends not to
be “recurrent” - meaning that reactivation does not present periodically (Kennedy and
Steiner, 1994). Such differences could result from fundamental differences in
alphaherpesvirus chromatin biology (Kennedy et al.). With such hypotheses in mind,
researchers needed suitable animal or cell models with which to evaluate them.
While VZV can infect a variety of cell types and is known take up latent infection
in cranial, dorsal root, and autonomic ganglia (Mahalingam et al., 2019), researchers are
currently lacking a suitable animal model to study the life cycle stages of VZV. Many
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attempts have been made over the years to establish a competent animal model of infection
and disease. Mice, cotton rats, and guinea pigs in particular (which were successfully
employed in the study of HSV-1), have been employed in attempts to establish a viable
animal model of infection (Takahashi et al., 1975; Myers et al., 1980; Matsunaga et al.,
1982; Wroblewska et al., 1982; Myers et al., 1985; Walz-Cicconi et al., 1986; Myers et al.,
1991; Wroblewska et al., 1993).
Interestingly, it has been found that simian varicella virus (SVV) infection in nonhuman primates produces varicella, but the main drawback to this particular non-human
primate animal model, although it has provided many insights, is that it is a very expensive
model to study (Mahalingam et al., 2019). Unfortunately, while a cost-effective animal
model capturing the full spectrum of infection and disease has not been successfully
created, attempts undertaken to use post-mortem autopsied human ganglia have also been
left wanting. Relying on tissue from recently deceased donors presents its own challenges
as the decomposition process has already begun and obtaining adequate amounts of viral
DNA from samples can prove challenging (Kennedy et al., 2015).
Concerning in vitro models, quite a few attempts have been made with varied
success. Gershon et al., created a model with enteric neurons isolated from adult guinea
pigs and from fetal mice (Gershon et al., 2008). ORF61 protein is capable of inducing
reactivation in this model (Kennedy et al., 2015). For as of yet not understood reasons, the
viral transcriptome of non-productive neuron infection is similar to that of productive
infection of human lung fibroblasts (Kennedy et al., 2015) – a model that will be discussed
in chapter 3. Yet for some reason in the neuronal cells, there is no evidence for the
accumulation of VZV DNA as there is with the HFL cells (Baird et al., 2014).
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Unfortunately, a latent state has not yet been achieved for HFL. In the last few years, human
embryonic stem cells have become successful cell models to study VZV infection
(Depledge et al., 2018b). Perhaps most excitingly, a cell model cultured from human dorsal
root ganglia tissue has been recently employed, demonstrating successful control over the
virus life cycle stage by the experimenter (Thellman et al., 2017). These HD10.6 cells may
be the most promising candidate model yet for an in vitro model of VZV infection.
With these improved models we can be sure that the biology mimics that of the host
as much of possible. This is especially important when trying to define the transcriptional
profiles of VZV that are subsequently used to delineate stages of the life cycle. It is from
the vista of these delineated stages from which we can survey the relevant chromatin
biology. The current paradigm holds that VZV, like HSV-1, is likely epigenetically
regulated (Kennedy et al., 2015). With the availability of cell models for particular stages
of infection, e.g. HFL cells for acute infection, the VZV transcriptional profiles, or kinetic
classes, of acute infection have been able to be characterized into immediate early (IE),
early (E), and late (L) kinetic classes primarily based on what is known about the more
thoroughly understood biology of the alphaherpesvirus HSV-1 as well as from some
experiments directly with VZV (Reichelt et al., 2009; Lenac Rovis et al., 2013; Depledge
et al., 2018b). It is hypothesized, as with HSV-1, that each set of genes in the kinetic class
is reliant on expression of the preceding class in a temporal fashion. Additionally, as with
HSV-1, IE genes serve a transcriptional regulatory role, E genes regulate DNA replication,
and L genes encode the structural proteins that are required for the formation of virions and
their subsequent departure out of the host cell (Depledge et al., 2018b). While studies have
been able to categorize VZV genes, difficulties have been encountered when trying to
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prepare VZV preparations with adequately high-titer to verify the existence of temporal
groups in VZV to the same degree as with HSV-1 (Cohrs et al., 2003; Kennedy et al., 2005;
Kennedy et al., 2015).
In VZV, ORF4, ORF10, ORF62, and ORF63 are transcriptional transactivators
(Kennedy et al., 2015) and are hypothesized to interact with host cell chromatin.
Kitchington et al. first identified them as being present in the VZV virion tegument
(Kinchington et al., 1992; Kinchington et al., 1995b). The formation of heterochromatin
structures on VZV gene promoters leads to viral gene transcriptional silencing (Everett et
al., 2006; Everett, 2010; Newhart et al., 2012). Additionally, ORF66, a VZV viral
serine/threonine kinase, can become phosphorylated to ORF66p, which, when activated,
will deactivate histone deacetylases. Thus, it has already been demonstrated that key viral
proteins do interact with host chromatin factors.
Interestingly, and importantly, ORF62 which encodes the VZV IE62 protein, is
described by Depledge et al. as homologous to “The dominant transcriptional regulator and
possibly only true immediate-early protein by Varicellovirus” (Kinchington et al., 1992;
Perera et al., 1992; Perera et al., 1993; Moriuchi et al., 1994; Tyler et al., 1994; Kinchington
and Turse, 1998; Ruyechan et al., 2003; Yang et al., 2006; Khalil et al., 2016). This is an
important claim indicating the prevailing sentiment that there is in fact a dominant
transcriptional regulator for each HHV. In the case of VZV, IE62 is indeed a major
transactivator protein, and can activate genes in all three kinetic classes of the acute
infection stage. It can perform this feat even with no other viral protein present (Depledge
et al., 2018b). The viral protein can do this during productive infection (acute or reactivated
stages) in a variety of cell types, underlining the role of common transcription factors and
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or viral proteins in coordinating infections (Depledge et al., 2018a; Depledge et al., 2018b)
(Baird et al., 2014; Jones et al., 2014; Markus et al., 2014; Sadaoka et al., 2016). In fact,
there are currently four suggested immediate early genes, all of which could potentially
interact with host chromatin factors to modulate transcription and thus viral life cycle. They
are ORF4, ORF61, ORF62, and ORF63 (Depledge et al., 2018b). The respective protein
products IE4, IE61, and IE63, have been shown to have a small to negligible effect on the
ORF62 promoter, providing further evidence that viral protein IE62 (encoded by ORF62)
is indeed the true major transactivator protein for VZV. (Kost et al., 1995; Michael et al.,
1998; Wang et al., 2009; Ruyechan, 2010; Depledge et al., 2018b).
Like the latency-associated transcript (LAT) of HSV-1, IE63 is thought to play an
important role in the latent stage of the VZV life cycle where, as with all HHVs, viral
transcription is mostly silent. IE63 is nucleus-localized and highly phosphorylated, and
likely represses transcription through histone modification, indicating an important role for
chromatin interactions with this viral gene product. IE63 has only been observed in tissue
culture cells but its transcripts have been found in ganglia, suggesting the protein itself may
be present in ganglia where it could inhibit VZV-induced apoptosis (Kinchington et al.,
1995a; Sadzot-Delvaux et al., 1998; Di Valentin et al., 2005; Hood et al., 2006; Ambagala
et al., 2009; Mueller et al., 2009; Mueller et al., 2010; Pugazhenthi et al., 2011; Ouwendijk
et al., 2016). VZV IE63 protein, most likely represses transcription through histone
modification (Kinchington et al., 1995a; Sadzot-Delvaux et al., 1998) (Di Valentin et al.,
2005; Ambagala et al., 2009; Mueller et al., 2009; Mueller et al., 2010). However, mostly
transcripts, and not the protein itself (with few exceptions) have been found in autopsied
trigeminal ganglia with a PMI (post-mortem interval) under nine hours (Mahalingam et al.,
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1996; Kennedy et al., 2000; Zerboni et al., 2010a; Zerboni et al., 2010b; Ouwendijk et al.,
2012a; Ouwendijk et al., 2012b; Kennedy et al., 2015). Because ORF63 is also a key IE
transactivator it would have to be altered in some way to change its function from activating
virus transcription to repressing virus transcription – and chromatin structural alteration is
one means by which this could be achieved.
Even more recently, a Biorxiv preprint by Depledge et al., from 2017, explains that
a newly identified transcript, that they call VLT (for VZV latency transcript), could play a
larger role in VZV latency than IE63. VLT may be able to limit IE61’s histone deacetylase
inhibitor activity (Wang et al., 2009; Boutell and Everett, 2013) which would contribute to
maintaining chromatin repression during VZV infections. In turn, this chromatinization
would limit viral gene transcription in VZV infection (Depledge et al., 2017, Biorxiv
preprint 2017). This newly identified VLT, in one or more of its isoforms could be the key
gene in maintaining latency. If this is the case, looking for chromatin interactions with this
newly identified transcript, particularly with regards to CTCF, could greatly improve our
understanding of the role that host cell chromatin biology plays in the switch between acute
and latent VZV infections. But it should also be noted that VLT differs markedly from the
key latency transcript of its cousin HSV-1. The HSV-1 latency associated transcript (LAT),
unlike VLT (at least demonstrated in vitro at this point), encodes miRNAs, is involved in
blocking apoptosis, and can downregulate the expression of the IE transactivator ICP0.
Whereas, we do not see such similarities with VLT as of yet (Depledge et al., 2017, Biorxiv
preprint)(Perng et al., 2000a; Perng et al., 2000b; Umbach et al., 2008).
A variety of reactivating stimuli have been identified in different HHVs across
different time points and models. Some HHV reactivating stimuli were discussed in earlier
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sections of this chapter and in the case of the newly employed HD10.6 model of VZV
infection, depletion of nerve growth factor or inhibition of PI3Knase excitingly leads to
reactivation of the virus. PI3Kinase has been shown to modulate levels of a variety of
histone marks (Spangle et al., 2017) which presumably led to decreases in repressive marks
and repressing viral transcription during latency. For example, in the Human
gammaherpesvirus Kaposi sarcoma-associated herpesvirus (KSHV/HHV-8), stress has
been shown to lead to the dissociation of the CTCF-cohesin ring that binds the episomal
virus genome to the host cell genome. This action then leads to the release of paused RNA
polymerase II during latency (Kang and Lieberman, 2011; Chen et al., 2017). As mentioned
earlier CTCF-cohesin ring complexes can bring together portions of different
chromosomes, transforming the three-dimensional higher order chromatin structure in a
manner that allows for the regulation of viral transcription (Kagey et al., 2010). The
recruitment of RNA polymerase II to CTCF/cohesin complexes, and/or the unpausing
thereof, may contribute to reactivation in alphaherpesviruses such as VZV (Chernukhin et
al., 2007; Wada et al., 2009; Kennedy et al., 2015). Stress has long been indicated in the
reactivation of HHVs (Rooney et al., 2019) and reactivation of VZV could potentially
proceed via a similar route to KSHV. Again, as better cell models are developed, and
interrogative techniques refined, these more macroscopic questions can begin to be
addressed within the context of HHV chromatin biology. The aforementioned development
of the HD10.6 human dorsal root ganglion-derived in vitro cell model will allow
alphaherpesvirus researchers to finally have a viable cell model that closely mimics the in
vivo infection physiology with which to study the acute, latent, and reactivated forms of
VZV infection.
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With such a model, our understanding of the complex interplay of chromatin
biology and VZV in the host cell nucleus will likely accelerate. We will be able to better
understand the higher order chromatin structures, epigenetic factors (e.g., histone marks
and the regulation of histone modifying enzymes), and overall chromatin states, that likely
work in tandem with the complex cellular and viral pathways to regulate the VZV life
cycle.

Concluding remarks

In this chapter, I have introduced the basic virology of Human herpesviruses and
their role in human disease. I then proceeded with a brief overview of human/host cell
chromatin biology and specifically highlighted the importance of the transcription factor
CTCF. Following a brief overview of current genomics methodologies employed in the
study of chromatin biology, I moved to a review of the literature encompassing our current
understanding of the role of chromatin biology in the HHV life cycle . I began largely
chronologically with a discussion of the literature relevant to EBV and HSV-1, about which
most of our knowledge of chromatin and HHVs is derived, and ended with an examination
of the state of our understanding of the chromatin biology of HHV-6A and VZV infections.
Within the context of HHV chromatin biology, comprehension largely recapitulates
chronology. I have also tried to arrange the discussion within the boundaries of the
individual life cycle stages and kinetic transcriptional classes that are characteristic of all
HHVs.
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While there is a relatively less known about HHV-6A and VZV, this is precisely
why these viruses require the attention of virologists and chromatin biologists. The fact
that HHV-6A integrates into subtelomeric regions of the host genome or that tractable
animal models of VZV infection have not been achieved, are to emphasize that these
viruses as all the more deserving of our scientific endeavor in my opinion.
In the ensuing chapters of this dissertation, I will present my contributions in
uncovering the higher order chromatin interactions and chromatin states in HHV-6A and
VZV in their latent and acute life cycle stages, respectively. In chapter 2, I demonstrate the
successful establishment of latent infection in the best current in vivo cell model we have
for HHV-6A infection – the HEK293/ciHHV-6A model. I characterize the chromatin state
as well as the higher order chromatin interactions that the virus makes with the host cell
genome. In addition, I characterize the chromatin landscape of the HHV-6A latent infection
in both the ciHHV-6A cell model and in the patient-derived cell model as well as in primary
lymphocytes from patients with iciHHV-6A. Finally, I present a novel computational
genomics methodology that I developed to identify sites of HHV-6A integration using
high-throughput sequencing data, the first time such a task has been achieved. In chapter 3
I successfully characterize the higher order chromatin structures and chromatin states of
the HFL cell model of acute VZV infection. Building off genomics and computational
techniques that I developed for my work in chapter 2, I proceed to employ the above
methodology, along with other genomics technologies, to identify higher order chromatin
associations and patterns of CTCF occupancy in acute VZV infection that is countervailing
to the current understanding of the role that CTCF plays during an acute VZV infection
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and hints at its potential role in regulating the chromatin structure that is hypothesized to
modulate the VZV life cycle.
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Abstract

Human herpesvirus -6A and 6B (HHV-6A/B) can integrate their genomes into the
telomeres of human chromosomes. Viral integration can occur in several cell types,
including germinal cells, resulting in individuals that harbor the viral genome in every cell
of their body. The integrated genome is efficiently silenced but can sporadically reactivate
resulting in various clinical symptoms. To date, the integration mechanism and the
subsequent silencing of HHV-6A/B genes remains poorly understood. Here we investigate
the genome-wide chromatin contacts of the integrated HHV-6A in latently-infected cells.
We show that HHV-6A becomes transcriptionally silent upon infection of these cells over
the course of seven days. In addition, we established an HHV-6–specific 4C-seq approach,
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revealing that the HHV-6A 3D interactome is associated with quiescent chromatin states
in cells harboring integrated virus. Furthermore, we observed that the majority of virus
chromatin interactions occur towards the distal ends of specific human chromosomes.
Exploiting this finding, we established a 4C-seq method that accurately detects the
chromosomal integration sites. We further implement long-read minION sequencing in the
4C-seq assay and developed a method to identify HHV-6A/B integration sites in clinical
samples.

Introduction

Human herpesvirus 6A (HHV-6A) and 6B (HHV-6B) are two closely related and
ubiquitous betaherpesviruses (Zerr et al., 2005). Most people are infected with HHV-6B as
infants, while the etiology of HHV-6A remain poorly defined (Okuno et al., 1989).
Following primary infection, HHV-6A/B establishes latency in the host for life (Flamand,
2018). During this latent state, viral gene expression and viral load are not detectable
(Saviola et al., 2019b). However, the virus can sporadically reactivate in the host, resulting
in the production of infectious virions and viral transmission (Endo et al., 2014). HHV6A/B reactivation has been linked to a variety of pathologies including encephalitis, graft
rejection and a spectrum of other diseases (Aimola et al., 2020).
HHV-6A/B are unique among human herpesviruses as they are able to integrate
their genomes into the telomeres of human chromosomes (Arbuckle et al., 2010;
Osterrieder et al., 2014). Chromosomal integration of HHV-6A/B occurs very efficiently
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in vitro and is dependent on telomere sequence arrays present at the ends of the virus
genome (Wallaschek et al., 2016; Gravel et al., 2017). HHV-6A/B can also integrate into
the germline, resulting in individuals harboring the virus in every nucleated cell of the body
and inherit it to their offspring. This inherited chromosomally-integrated HHV-6 (iciHHV6) is present in about 1% of the human population (Kaufer and Flamand, 2014) with several
independent integration events occurring thousands of years ago (Aswad et al., 2020).
Integration into the telomeres allows maintenance of the virus genome in iciHHV -6
individuals and latency (Arbuckle et al., 2010); however, it remains unknown if integration
into the telomeres contributes to the silencing of the virus genome.
Here, we explored if, how, and when the HHV-6A genome is silenced upon
integration using an in vitro integration model and RNA sequencing. We demonstrate that
HHV-6A genes are silenced upon integration over the course of 7 days. We employ circular
chromosome conformation capture assays (4C-seq) to assess the higher order chromatin
structures formed between the virus and host genome in these cells. Because HHV-6A/B
integrate into highly repetitive telomeric regions of individual human chromosomes, we
used 4C-seq-based analysis as a tool to identify integration sites. Our 4C-seq approach
employs novel scoring method as well as Oxford Nanopore minION long-read sequencing
to effectively identify integration sites in human telomeres. Overall, this study provides a
better understanding of the chromatin programs that may regulate HHV-6A latency and
provide novel diagnostic methods to determine chromosomal integration sites.
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Materials and Methods

Ethics

Specimens were obtained from the Fred Hutch Research Cell Bank, which prospectively
collects and cryopreserves peripheral blood mononuclear cells (PBMCs) from donors and
recipients. The University of Washington Institutional Review Board approved use of the
iciHHV-6 specimens from the Fred Hutchinson Cancer Research Center and use of
anonymized excess HHV-6-positive samples submitted for testing at the University of
Washington Virology lab.

Cell lines and virus

SMC cells harboring integrated HHV-6A virus (iciHHV-6A cells) were
immortalized following transduction with a lentiviral vector (pLenti CMV/TO SV40 small
+ large T (W612-1), a gift from Eric Campeau and obtained from Addgene (plasmid
#22298)) and expressing the SV40 T antigens. SMCs were cultured in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 20% fetal bovine serum (FBS), 1%
penicillin streptomycin (Pen/Strep), and 1% L-Glutamine. Human epithelial kidney 293 T
(293 T, ATCC CRL-11268) cells were cultured in the same medium but supplemented
with 10% FBS. All cells were maintained in 10 cm 2 flasks as a monolayer culture in a
humidified 5% CO2 air incubator at 37°C. Bacterial artificial chromosome (BAC)-derived
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HHV6A (strain U1102) expressing green fluorescent protein (GFP) under the control of
the HCMV major immediate early (IE) promoter (293-HHV-6A virus) was propagated in
J-Jhan cells as described previously (Tang et al., 2010b). 293 T cells were infected with
293-HHV-6A virus and GFP positive cells were isolated using a FACS AriaIII cell sorter
(BD Biosciences). Clones harboring the integrated 293-HHV-6A genome (ciHHV-6A
cells) were identified by quantitative PCR (qPCR) and HHV-6A integration was confirmed
by fluorescent in situ hybridization (FISH). iciHHV-6B+ human lymphocytes (NCBI
GenBank: KY315552) were isolated from an infected patient as described by Aswad et al.
(Aimola et al., 2020).

Fluorescence in situ hybridization

FISH was performed with digoxigenin-labeled bacterial artificial chromosome
(BAC) probes against both the HHV-6A genome and individual chromosomal reads
essentially as described previously (Kaufer et al., 2011; Kaufer, 2013). Slides were
mounted using DAPI Vectashield (Vector Laboratories) and images were taken with an
Axio Imager M1 (Zeiss).

RNA-Seq analysis

RNA was extracted from an HHV-6A infected 293T cell line using Trizol Reagent
(Life Technologies) and purified using Direct-zol RNA MicroPrep Kit (Zymo Research
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#R2060) following the manufacturer’s instructions. One microgram of total RNA was
depleted of ribosomal RNA (rRNA) using the KAPA RiboErase Kit (#KR1142) and
libraries were prepared using the KAPA Stranded RNA-seq Library Preparation Kit
(#KR0934). Libraries were quantified using Qubit (Life Technologies), and quality was
assessed using the Agilent Bioanalyzer High-Sensitivity DNA kit (Agilent Technologies).
Barcoded libraries were pooled and sequenced on an Illumina HiSeq 2000 to obtain 100bp paired-end reads. RNA-seq data were processed using STAR as described previously
(Dobin et al., 2013) using human (hg38) and a custom HHV-6A reference genomes
(NC_001664.4) modified to contain GFP transgenes. BAM files were sorted and converted
to SAM files using SAMtools (Li et al., 2009) and reads were counted with featureCounts
(Liao et al., 2014) against the corresponding viral GTF file and normalized in DESeq2
(Love et al., 2014). Alignment of viral reads across the HHV-6A genome was visualized
using the “seqsetvis” R library (J, 2020) and in-house scripts.

4C-Seq library preparation and sequencing

In order to identify the higher order chromatin structure and virus-host DNA
contacts, 4C-seq libraries were prepared using both ciHHV-6A and iciHHV-6A samples
as described previously (Krijger et al., 2020), using HindIII/DpnII restriction enzymes.
Cells were cultured as previously described (Saviola et al., 2019b) and fixed with 1%
formaldehyde prior to being snap frozen. For each 4C library, ten million cells were used
unless otherwise noted. Inverse PCR was performed in 50 uL reactions using 200ng 3C
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library template, 25 uL Q5 Hot Start High-Fidelity DNA Polymerase 2X Mastermix (New
England Biolabs), 1.5 ul of 10uM forward and reverse inverse PCR primers and water
under the following conditions: 30s 98°C, 10s 98°C, 30s 55°C, 2m 72°C, 5m 72°C for a
total of 25 cycles. PCR products were cleaned up using the PCR purification kit
(Thermofisher Scientific) using the B3 reagent to exclude fragments less than 300 base
pairs or with Ampure XP beads (Beckman Coulter) and eluted in water. Library indexing
was performed using the DNA HT Dual Index Kit (Illumina) or with custom dual indexing
primers with an additional 8 cycles of PCR. Indexing of nanopore libraries was performed
with custom 12-nucleotide dual index primers with 8 additional PCR cycles. All primers
sequences are listed in Supplemental Table 2.1. Libraries were pooled and sequenced with
either HiSeq2000 or MinION platforms. The experiments were performed with samples
from separate cell culture dates. For the Illumina viewpoint comparison libraries, two
replicates were performed for two separate viewpoints. For the ONP titration and viewpoint
comparison studies, one and two replicates were performed, respectively.

4C-Seq primer design

We developed a 4C-seq primer design tool 1 to facilitate the generation of the
inverse PCR primers necessary for 4C-Seq assays in a genome-agnostic manner for use
with experiments involving custom genomes (i.e., chromosomally integrated HHV-6A). A
fasta file containing the HHV-6A genome (NC_001664) was obtained from NCBI and

1

https://github.com/FrietzeLabUVM/4c_primer
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uploaded into the design tool, selecting HindIII and DpnII restriction endonucleases, and
minimum fragment sizes 500 bp for the first fragment and 300 bp for the second fragment
were used (van de Werken et al.).

4C-Seq analysis

4C-seq trans interactions were determined using a “window” method as described
by Kim et al. (Kim et al., 2020). Briefly, the virus viewpoint regions at the beginning of
the reads were trimmed off using Cutadapt (Martin) software and the remaining human
portions were aligned to the human UCSC hg38 reference genome using bowtie2 (version
2.3.5) (Langmead et al., 2009; Langmead and Salzberg, 2012). P-values for each mapped
base were then calculated for each 10kb window across all chromosomes using a Poisson
formula. Final, significant peak regions are then called using the MACS2 (version 2.2.7)
bdgpeakcall function (Zhang et al., 2008). Significant interacting trans peak regions were
identified using the above window method for each replicate, for each viewpoint, in both
the ciHHV-6A and iciHHV-6A samples. These regions were plotted as circos plots using
the Circlize R library (Gu et al., 2014). Bedtools (Quinlan and Hall, 2010) was used to find
the intersection of the trans regions and the 127 epigenomes 25-state imputation based
chromatin state model created with ChromImpute (Ernst and Kellis, 2012; Ernst and Kellis,
2015) and made available from the Wang Lab 2 (Jin Wook Lee). For ciHHV-6A cells,
chromatin state annotation was also performed using fetal kidney and fetal adrenal gland

2

https://egg2.wustl.edu/roadmap/web_portal/imputed.html#chr_imp
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tissues – also made available from the Wang lab 2. 4C trans peaks and signals were also
compared to signals for the repressive histone marks H3K9me3, NCBI GEO: GSE66530
(Hattori et al., 2016), and H3K27me3, NCBI GEO: (Lamb et al., 2019), in HEK293 cells
and compared to the same marks, NCBI GEO: GSE121984, in iciHHV-6A cells (Saviola
et al., 2019b).
4C-seq cis interactions were determined using the program peakC (Geeven et al.,
2018). Telomere content comparison was assessed by TelomereHunter (Feuerbach et al.,
2019). Illumina data was simulated using ART (Huang et al., 2012) set to HiSeq2500 data.
Reads were produced to cover the entire UCSC hg38 reference genome at 1X coverage.
Then, a number of simulated reads equivalent to the number of reads sequenced between
4C data were randomly sampled from the simulated data. TelomereHunter was run on all
samples and a non-parametric Wilcoxon test was performed to compare 4C-seq reads to
simulated reads.
To identify the chromosomes harboring HHV-6A integration, a scoring system was
developed and coded using the R programming language. Accordingly, trimmed reads
were aligned to the hg38 genome using bowtie2, or BWA-MEM (Li, 2013) for MinION
reads and each read that maps within 500 kb of any autosome terminus was scored. The
total scores for reads within these 500 kb regions are tallied and then compared to each
other in one of two ways. If replicates are available, a two-way ANOVA is first performed
with chromosome end sum scores as the outcome variable and individual chromosome
ends as the categorical predictor variable. TukeyHSD pairwise-post hoc tests are then
performed and the chromosome end with the highest mean -log10 p-value is determined to
be the most likely candidate. A significance of 0.05 was used for this approach. If replicates
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were not available for a specific viewpoint/cell type combination, the chromosome end
scores were all compared to each other using Wilcoxon non parametric tests. The
chromosomal end with the largest -log10 p-value adjusted for multiple test comparison was
chosen as the most likely candidate and an alpha of 0.05 was used as a cutoff of
significance. Furthermore, statistical ranking via the aforementioned pairwise post-hoc
tests from the algorithm score sums (for each chromosome end) to identify the ends of each
chromosome as most significant candidate for HHV-6A integration.

Results

Dynamics of HHV-6A gene expression during the establishment of latency

We recently reported that the chromosomally integrated HHV-6A genome exists in
a compacted transcriptionally silent state (Saviola et al., 2019b). To study the kinetics of
HHV-6A gene silencing upon HHV-6A infection, we performed a 7-day time course in
human 293T cells. 293T cells are susceptible to HHV-6A infection and were previously
established as a model for studying virus integration (Arbuckle et al., 2010; Gravel et al.,
2017; Saviola et al., 2019b). Cells were infected with recombinant HHV-6A virus
expressing GFP under the control of the major immediate-early (IE) HCMV promoter
(Tang et al., 2010a; Wallaschek et al., 2016). Infected GFP-positive cells were isolated by
FACS sorting 16 h post infection and subsequently cultured. The presence of the HHV-6A
genome was confirmed by qPCR and integration was validated by FISH at day seven post52

infection. Infected cells were collected daily until 7 days post-infection (dpi) and processed
for gene expression profiling via RNA-sequencing (Figure 2.1.A). The expression of all
HHV-6A genes progressively decreases over the 7-day period as visualized via a clustered
heatmap (Figure 2.1.B). The observed gene silencing over this period course can be
grouped into 3 clusters based on expression levels of all viral genes (early, mid and late).
The collective expression of genes is reduced over a 3 -day period, followed by near
complete silencing from 5-7 dpi (Figure 2.1.C). Thus, HHV-6A gene expression upon
infection is silenced within 7 days in 293T cells harboring the integrated virus genome.

Higher-order chromatin interactions of chromosomally integrated HHV-6A

The epigenetic mechanisms that regulate gene silencing in chromosomally integrated
HHV-6A/B remain poorly characterized. We previously demonstrated that the integrated
viral genome forms repressed heterochromatin domains (Saviola et al., 2019b). We further
hypothesized that higher-order chromatin interactions play a role in virus gene silencing.
To investigate higher-order chromatin interactions between chromosomally integrated
HHV-6A, we designed 4C-seq assays using distinct viewpoint regions designed against
distinct HHV-6A regions (Figure 2.2.A). To obtain the inverse PCR primers required for
4C analysis, we developed a genome agnostic 4C primer design tool (see methods). Two
distinct viewpoints (vp1 vs. vp2) were designed based on optimal fragment length and
restriction enzyme sequence along the length of the ~160 kb HHV-6A genome. The HHV6A genomic regions targeted by viewpoint vp1 and vp2 primers are located adjacent to the
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U39 gene-encoding glycoprotein B (gB) (position: 64 kb) and the U95 gene (position: 148
kb), respectively (Nicholas and Martin, 1994). With this approach, we assessed the HHV6A chromatin conformation in a previously described 293T cells line harboring the
chromosomally integrated HHV-6A (ciHHV-6A) (Saviola et al., 2019b) and in iciHHV6A+ patient-derived cells (iciHHV-6A). We obtained approximately 2 hundred thousand
to 2 million reads per viewpoint replicate across 2 independent 4C-seq assays, of which
85.93% of reads mapped to the combined reduced human+HHV-6A genome (hg38 +
NC_001664.4 or recombinant GFP genome, depending on the sample) (Supplemental
Table 2.2.1). Significant ‘trans’ interacting regions between the HHV-6A genome and the
human genome were identified for both in vitro-derived (ciHHV-6A) and patient-derived
iciHHV-6A cells (Figure 2B). For ciHHV-6A, we found a total of 6 high-confidence
interactions that intersected between viewpoints, and a total of 3 interactions were between
viewpoints for iciHHV-6A cells. In addition, a number of cis-interacting regions were
identified for both viewpoints (Figure 2.2.C; Supplemental Table 2.2.2 and 2.2.3). In
line with other 4C-seq results (Krijger et al., 2020) there were relatively high densities of
interactions that occur near and between viewpoints. Overall, there were a number of cis
interactions identified in each cell types suggesting that virus genome may reside in a
highly folded compartment similar to a topologically associated domain.
To assess the chromatin features of the identified interaction regions, we annotated
the identified interacting human regions using available chromatin state segmentations
compiled from multiple human tissue types (Ernst and Kellis, 2015). This annotation
dataset is derived from 12 epigenetic features and from 127 original reference epigenomes.
We found that the human chromatin that interacted with HHV-6A is largely composed of
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quiescent and heterochromatin states, whereas enhancer and transcriptional activation
annotations occur to a lesser degree (Figure 2.2.D). Similarly, chromatin state annotations
derived from single representative cell types exhibit similar chromatin state patterns at the
HHV-6A interacting genomic regions (Supplemental Figure 3). We further inspected the
enrichment of the repressive histone modifications H3K9me3 and H3K27me3 at both
ciHHV-6A and iciHHV-6A 4C-seq peaks using ChIP-seq data from each respective cellline (Supplemental Figure 2.2). In both ciHHV6-A and iciHHV6-A, the majority of the
significant 4C-seq peaks overlap directly with these repressive histone marks. These results
indicate that the integrated HHV-6A genome forms higher order chromatin structures
within the viral genome as well as with regions of the human genome that are enriched
with repressive chromatin. Overall, these results provide insight into HHV-6 chromatin
structures within the host cell nucleus.

Proximity chromatin ligation reveals integration sites

HHV-6A/B integration sites were first detected by FISH (Nacheva et al., 2008),
and the virus-host junction of three different integrations was sequenced using a PCRbased approach. Although PCR amplification and Sanger sequencing provided sequence
information, this approach requires previous knowledge of the chromosomal location of
the virus genome (Huang et al., 2014; Tweedy et al., 2016) and is prone to amplification
biases and sequencing errors due to the repetitive nature of the region (Arbuckle et al.,
2010; Arbuckle et al., 2013; Huang et al., 2014; Ohye et al., 2014; Gulve et al., 2017).
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Genome-wide mapping of short read sequence data to human subtelomeres is challenging
due the repetitive nature of subtelomeric regions. It is well-documented that higher order
chromatin interactions largely occur in cis in large megabase pair (Mbp)-sized
topologically associated domains (TADs) (Szabo et al., 2019). Because HHV-6A
integrates into a host chromosome, the extra-chromosomal trans 4C-seq interactions that
are identified should behave like endogenous intrachromosomal cis interactions, i.e., 4Cseq should show distinct interacting regions between the host and HHV-6A genomes. With
this in mind, we hypothesized that 4C-seq data could identify HHV-6A integration sites,
and visualization of 4C alignments to the human genome reveals particular telomeric ends
that are enriched with 4C signal. Figure 2.3.A shows enrichment at the distal end of
chromosome 15q relative to the rest of the genome in ciHHV-6A cells. In addition,
clustering of reads at the distal ends of chromosome 15q and chromosome 19q in ciHHV6A and iciHHV-6A, respectively, can be seen in Figure 2.3.B. Further, we identified
significantly more telomeric sequences in our 4C-seq data relative to simulated reads of
equal size and GC content (Supplementary Figure 2.1). To enable systematic analysis of
HHV-6A integration sites using 4C-seq, we established a scoring procedure to assess the
chance of integration across all chromosomes based on clustered read mapping (see
methods). The ends of chromosome 15q and chromosome 19q rank as the highest scoring
chromosome ends for ciHHV-6A and iciHHV-6A, respectively, in terms of read mapping
density and integration probability (Figures 2.3.C and 2.3.D). This indicates that these
two chromosome ends were the most likely candidates for harboring integrated HHV6A in
the ciHHV-6A and iciHHV-6A cell models, respectively. We confirmed that these
chromosomal regions harbor the integrated virus by FISH using probes specific for the
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virus genome and the respective human chromosomes (Figure 2.3.E). The integrated
HHV-6A genome indeed was present in the respective chromosomal loci, highlighting that
the 4C-seq analysis is an unbiased method to identify HHV-6 chromosomal integration
sites.

4C-seq integration site analysis using Nanopore sequencing

Next generation sequencing technologies have made it possible to generate large
quantities of sequence data required for a variety of genomic assays including 4C -seq.
However, 4C-seq library sizes derived from inverse PCR are relatively large and often
difficult to cluster on Illumina flowcells. Long read sequencing platforms, including the
Oxford Nanopore Technologies (ONT) minION, have become common an option for long
read sequencing and have been applied for structural genome mapping approaches (De
Coster et al., 2019). We therefore evaluated minION sequencing on the 4C-seq libraries as
a method to identify integration sites from HHV-6 samples. We sequenced the same 4Cseq libraries with minION flowcells and obtained 150,646,076 bp of demuxable reads with
a mean read length of 604.0 bp for the ciHHV-6A and iciHHV-6A sequencing run. For
the cell counts titration sequencing run we obtained 419,121,238 reads with a mean read
length of 730.4 bp. Alignment of reads that pass quality filters to the human genome reveals
a similar grouping of telomere proximal reads at 15q and 19q for ciHHV-6A and iciHHV6A samples, respectively (Figure 2.4.A). Current 4C-seq peak calling software are not
well-suited for long-read with low quality scores. We thus adapted our own method based
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off clustering of adjacent 4C-seq reads (methods). Using this approach, we found an overall
comparable number of trans peaks called between replicates (Figure 2.4.B). Thus, minION
sequencing data represents a sequencing method to generate 4C-seq read data.
We applied the minION 4C-seq reads to investigate the required input material
required for identifying HHV-6A integration sites by titrating the number of cells for 4C
library construction. We compared a range of input cell quantities for 4C library
construction (10 4 to 10 7 cells) using the iciHHV-6A cells combined with minION
sequencing (Figure 2.4.C). These results confirm that 19q harbors the integrated HHV-6A
genome for iciHHV-6A SMC cells, and this can be reliably detected in as few as 100,000
cells for the 4C-seq assay. However, using just 10,000 cells 19q also scores highest,
however there appears to be some ambiguity as 14q also scores highly. Finally, we also
applied minION 4C-seq to detect HHV-6A integration sites using frozen patient-derived B
cells from iciHHV-6A+ individuals for this assay. Like the iciHHV-6A SMC samples, 19q
also scores as the likely integration site for HHV-6 integration in additional patient-derived
lymphocyte samples (Figure 2.4.D). FISH validation using chromosome 19q probes of the
patient samples confirms HHV-6A integration into chromosome 19q (Aswad et al., 2020;
Wight et al., 2020). Thus, 4C-seq libraries can be generated as little as 10,000 cells and
using cryopreserved lymphocyte cell samples. In summary, this workflow allowed us to
efficiently identify the chromosomal ends that most likely harbor the integrated virus
genome.
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Discussion

HHV-6A and HHV-6B, potentially along with HHV-7 (Prusty et al., 2017) are the
only known pathogens to integrate into human telomeres (Gulve et al., 2017; Prusty et al.,
2017). While the chromatin mechanisms that govern HHV-6A latency and reactivation
remain overall poorly characterized, it has been suggested that integration of the HHV 6A/B genome facilitates the maintenance of the virus genome latency (Arbuckle et al.,
2010; Huang et al., 2014). The establishment quiescent/latent states has been investigated
in a number of cell lines including 293T cells (Gravel et al., 2017). In these in vitrogenerated cells and patient-derived iciHHV-6A cells, the virus genome transcriptionally
silent (Saviola et al., 2019b). These global RNA-sequencing data are in contrast to Kondo
et al., who detected a few latency-associated transcripts by qRT-PCR (Kondo et al., 2002b).
To investigate the establishment of a latent-like expression profile, we infected cells
and performed RNA-sequencing during the first days of integration. Indeed, in early time
points (days 1-3, Figure 2.1), we detect high expression levels of all HHV-6A RNA
transcripts. However, over the period of 5 days post infection the viral transcripts were
significantly reduced and became virtually undetectable by 7 days post infection. It remains
unclear whether the RNA-expression is derived from an integrated or extrachromosomal
virus genome. However, after 7 days post infection only integrated virus genome were
detected when gene expression is absent.
Our prior analyses of the heterochromatin enrichment profiles of integrated HHV6A genomes revealed that the integrated viral genome was resistant to MNase digestion,
suggesting that the viral genome forms a compact chromatin domain (Saviola et al.,
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2019b). Consistent with these findings, they found that the viral genome was enriched with
the repressive posttranslational histone modifications H3K27me3 and H3K9me3. These
results suggested that repressive chromatin structures likely play a role in viral gene
silencing.
To further explore the chromatin-mediated mechanisms associated with silent
chromatin, we applied the 4C-seq to determine the genome-wide chromatin contacts of
HHV-6A based on nuclear proximity ligation. 4C-seq is designed to examine the genome
for sequences contacting a selected genomic site of interest. Accordingly, we designed 4Cseq assays with viral viewpoint primers to identify the HHV-6 chromatin interactome. We
generated high-resolution contact profiles for distinct viral viewpoints and detail the
chromosomally integrated HHV-6 genomic organization. We find that clonally expanded
in vitro HHV-6A (ciHHV-6A) cells display unique virus-host interactions relative to
patient-derived iciHHV-6A cells. Overall, there are not many significantly detected interchromosomal or trans contacts across the human genome. However, the interactions that
we detected were largely enriched with chromatin annotated as being quiescent or
heterochromatin. Overall, this analysis indicates that the HHV-6A genome folds in a
manner that it is capable of physically interacting with repressive chromatin and may
explain some of the mechanisms used to silence virus gene expression in chromosomally
integrated HHV-6A cells. To our knowledge, these results were the first reported chromatin
interaction for a betaherpesvirus, and it is possible that these interactions between the virus
and repressive chromatin elements play distinctive functions in HHV-6A latency.
We also found that the integrated HHV-6A genome forms several shared intrachromosomal or cis contacts between the two ciHHV-6A cell types and that the virus
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genome exists in a highly folded state. It is possible that the HHV-6 genome forms a
topologically associated domain within the virus and neighboring human sub -telomeric
regions. Topologically associated domains or TADs are large regions of local
intrachromosomal interactions. In support of viral TAD formation, we find a strong
enrichment of telomeric sequence content in HHV-6A 4C-seq data. Interestingly, these
domains appear to extend past the non-unique subtelomeric regions into the unique portion
of the human genome and aligned reads cluster to the ends of 15q and 19q stand out in this
data. Importantly, these regions score as the strongest interaction sites and confirm as being
the integration chromosomes in independent FISH assays using probes to both virus and
the identified chromosomal regions. Further experimental and computational methods
including HiC and TAD calling algorithms are required to comprehensively determine
HHV-6A TAD structures.
The identified trans interacting human sites as well as the strong signals along the
distal ends of distinctive human chromosomes indicated that the 4C assay may prove useful
to identify integration sites. Current 4C-seq peak calling methods are designed to identify
interacting peaks based on monotonic shape as well as proximity to viewpoint regions. In
addition, most 4C-seq peak calling methods are not designed to detect trans interactions
between two unrelated genomes, although recent methodological improvements have been
reported in the case of Epstein Barr Virus (Kim et al., 2020) and we were able to
successfully apply such a method to our Illumina sequencing data.
To further establish 4C assays for calling integration sites, we developed a simple
scoring method that scores and statistically evaluates candidate chromosomal integration
sites. This method bins read alignments that occur at the distal 500 kb ends of each
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chromosome and performs statistical analysis to provide a useful score to evaluate
chromosomal integration. For the ciHHV-6A and iciHHV-6A samples, this method
accurately predicts the integration site. We further used this method to evaluate reads
derived from a minION flow cell from a titration experiment with single replicates for each
titration level. In each case, this method accurately identified validated integration regions
as top scoring candidate regions and helped to demonstrate that as f ew as 10,000 – 100,000
cells can be used as input for 4C-seq assays.
Chromatin conformation capture methods have been previously applied to the study
of physical chromatin interactions between host and viral genomes. For herpesvirus
latency, HiC was used to demonstrate that the latent EBV will disassociate from repressive
heterochromatin compartments and form new associations with transcriptionally
permissive euchromatin upon reactivation (Moquin et al., 2018). 4C-seq was recently used
with Burkitt’s lymphoma cells, showing that the latent EBV episomes make contact with
transcriptionally repressive H3K9me3 sites as well as attachment sites associated with
transcriptionally silent genes (Kim et al., 2020). Finally, 4C-seq has been applied to study
the chromatin structures of the latent HIV proviral genome (Dieudonne et al., 2009).
Chromatin conformation capture libraries generally require a large amount of
starting material, i.e. as many as 10 million cells (Nilsen, 2014). To enable the 4C assay
towards a routine and throughput method to identify integration sites in clinically relevant
samples, we performed the assay using a titration of cell numbers ranging from 10 4 to 107
cells. Indeed, our titration results demonstrate that we can reliably detect sites as low as
10,000 cells (Figure 4). However, with this low number of cells we identified a few
potential spurious hits including chromosome 14. Another adaptation to the assay, is the
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use of the Nanopore sequencing platform. This newer sequencing platform has several
advantages over Illumina, including cost and speed of data generation. In particular
relevance to this study, 4C libraries generated via inverse PCR can be greater than 1 kb in
size. The resulting Illumina libraries can be difficult to cluster, resulting in a poor output
from the sequencing run at a higher cost. We therefore used Nanopore to generate data for
integration analysis and find that using our scoring method that this is adeq uate for
integration analysis. Due to the reduced read quality and relatively lower output, it remains
to be determined if Nanopore-derived 4C-seq analysis compares to Illumina analysis for
interaction peak analysis.
Finally, it is important to note that the resolution of 4C-seq can be as high as 1-2
Mbp for 4C-seq interactions (Krijger et al., 2020) and the annotation of the corresponding
physical interactions can be challenging. Higher resolution 3C methods, including capture
HiC can be applied in future studies to better study the nature of these identified physical
interactions. These issues of scale are particularly important in the case of HHV-6A
integration because the interactions between the virus and the host genomes are akin to cistrans interactions. The HHV-6A genome is simultaneously acting like an independent
chromosome (trans) that integrates into a particular human chromosome (cis) and we need
to consider these interactions as a special case of 4C interactions, i.e., something like a
“cis-trans” interaction. Because of this simultaneous “cis” nature, we chose to focus on the
trans interactions in the 1-2 Mb range that is typical of the size of cis interactions reported
in literature. Future studies aimed at more precisely defining the cellular factors and human
contact points made by integrated HHV-6 will facilitate a more mechanistic understanding
of viral gene silencing.
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In summary, we have utilized a 4C-seq framework to identify both trans (virushost) and cis (virus-virus) interactions that are formed within the human host cell nucleus.
We further utilized this assay towards the unbiased identification of HHV-6A integration
sites in human chromosomes. This optimally complements our recently developed optical
mapping approach for the integrated HHV-6 genome (Wight et al., 2020). While research
into the mechanisms and factors governing HHV-6A integration is an active area of
ongoing research (Aimola et al., 2020), implementation of the methodology presented in
this study provides important information on the silencing of the integrated virus genome
and lays the foundation for high throughput detection of HHV-6A/B integration sites in
clinical samples.
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Figures and figure legends

Figure 2.1 RNA-Seq time course reveals the establishment of transcriptionally silent
state upon HHV6A infection. A. 293T cells were infected with ciHHV-6A and GFP
expressing cells were isolated by FACS. RNA-seq analysis was performed on the cells
during the integration phase at the indicated days post infection (dpi). B. Cluster analysis
of RNA-seq expression of HHV-6A GFP genes, showing expression values of normalized
counts with a pseudo-count of one C. Boxplots of mean viral gene expression shown for
each time point group. D. RNA-seq signal plotted across the HHV-6A genome for each
day. Viral expression is almost completely absent by day 7 indicating the establishment of
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a transcriptionally silent latent infection. At the later timepoints (e.g., days 4-6), two
prominent peaks can be seen flanking the U41 and U42 genes, the origin of lytic DNA
replication (oriLyt) and the CMV promoter and GFP regions.
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Figure 2.2. Chromatin interactions of chromosomally integrated HHV-6A. Circular
Chromosome Conformation Capture (4C-seq) assay was employed using chromosomally
integrated HHV-6A cell models to investigate virus-host chromatin interactions. A. 4C-seq
assay with ciHHV-6A cells. The integrated HHV-6A genome (yellow) is shown with its
flanking telomeric regions (gray) and telomere-proximal unique portions of a human
chromosome (black). Indicated are the restriction endonucleases sites used in the 4C-seq
assay (HindIII and DpnII are indicated as ‘H’ and ‘D’, respectively). Inverse PCR was
performed with distinct viewpoint primers and analysis to identify interaction regions was
performed as shown. B. HHV-6A trans interactions for the in vitro integration model
(ciHHV-6A) and the chromosomally inherited iciHHV-6A cell model (iciHHV-6A).
Significant interactions are visualized using circos plots - both viewpoints are shown for
ciHHV-6A cells (left) and for iciHHV-6A cells(right). C. HHV-6A cis interactions
identified for two separate HHV-6A viewpoints. Inverse primers were designed for two
viewpoint regions chosen at ~ 64 kb and 148 kb along the HHV-6A genome. Note that the
HHV6A-GFP genome is slightly larger than the canonical HHV-6A genome due to the
additional presence of recombinant elements. D. Host interaction regions (trans) are
annotated using the 127 epigenomes 25-state chromatin state model database for ciHHV6A (left) and iciHHV-6A (right). The host interaction regions contain the indicated
chromatin database annotations. Displayed in boxplots (top) and as a heatmap (below).
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Figure 2.3. Identification of chromosome ends harboring integrated HHV-6A. A.
Genome-wide karyotype plot showing 4C-seq read mapping density for iciHHV-6A,
viewpoint 6a10 replicate 1, across each human chromosome. B. Karyotype plots showing
4C-seq read mapping density for chromosomes 15 and 19 for each cell-line. C. 4C-seq
signal clustering method to score all the reads within 500 kb from each chromosomal end.
The sum of these scores is represented in the bar plots for each replicate for each viewpoint
in both ciHHV-6A and iciHHV-6A cell types. D. statistical measure of the likelihood that
a specific chromosome harbors integrated HHV-6A. For datasets that contain replicates,
an ANOVA was performed using the score from our algorithm across all chromosome ends
followed by pairwise Tukey’s HSD post-hoc tests. The “p-score” is the mean -log10(pvalue) value for all pairwise comparisons divided by (normalized by) the maximum mean
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-log10(p-value). E. Integration sites were confirmed via fluorescent in situ hybridization
using probes complimentary to chr19q (Gerstein et al.) and the HHV-6A genome (BenFredj et al.) in iciHHV-6A (SMC) cells.

Figure 2.4. MinION-based 4C-seq HHV-6A integration analysis. A. Karyotype plots
showing 4C-seq MinION read mapping density at chr15q and chr19q for ciHHV-6A and
iciHHV-6A cell models. B. Chromosomal end integration site analysis using 4C-seq with
MinION reads. As in Figure 3D, a statistical measure of the likelihood that a specific
chromosome harbors integrated HHV-6A. Plotted are only the top scoring chromosome
ends. C. A titration series of cell dilutions was used for 4C-seq MinION analysis and was
scored with statistical testing to identify potential HHV-6A integration chromosome ends.
D. MinION 4C-seq analysis results of a frozen iciHHV-6B+ human lymphocyte sample.
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CHAPTER 3

Introduction

Varicella-zoster virus, or VZV, is a ubiquitous Human alphaherpesvirus that
primarily causes childhood varicella (chickenpox) and zoster (shingles) upon reactivation
in adults. Like all herpesviruses, VZV can establishes a latent infection after resolution of
primary infection: VZV does this within host cell neurons of the peripheral nervous system.
To further uncover chromatin states and structures underlying the acute VZV infection, as
well as the chromatin dynamics hypothesized to mediate the establishment of latency , a
thorough characterization of the chromatin landscape within the nucleus of acutely infected
cells is required.
Alphaherpesviruses, like VZV, have a relatively short replication cycle that is part
of the acute and reactivation stages of the virus life cycle. During this acute replication
cycle, virus gene expression is exquisitely choreographed resulting in immune evasion, the
reprogramming of host cell functions to express various classes of virus genes, genome
replication, packaging of said genome into virions, and the release of these virions form
the host cell to proliferate the infection (Kennedy et al., 2015). For herpes simplex virus
type 1 (HSV-1) the prototype Human alphaherpesvirus, these events typically are
completed within 8 hours and involve coating of the incoming protein free virus DNA with
mobile histones that soon acquire posttranslational markings indicative of heterochromatin.
While forays into the understanding of the chromatin control of alphaherpesviruses like
VZV and HSV-1 have begun to be unraveled over the last decade (Cliffe et al., 2013), most
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of the findings have been identified in HSV-1, while the picture remains far less clear for
VZV in terms of the epigenetic programs, and chromatin structures and states comprising
the chromatin biology that mediates this complex, dynamic process.
To begin to glean insight into the dynamic chromatin biology mentioned above, I
primarily focus on employing 4C sequencing and ChIP sequencing to advance our
knowledge of this complex and dynamic relationship – particularly with regards to the
chromatin organizer and transcriptional insulator CTCF. Chromosome confirmation
Capture Circular sequencing or “4C-Seq” was first developed almost a decade ago (van de
Werken et al., 2012), yet its potential to unravel the viral interactions within host cells has
yet to be realized in the realm of Human alphaherpesviruses. In fact, to my knowledge,
4C-Seq has only been applied to the gammaherpesvirus EBV and only as recently as 2020
(Kim et al., 2020).
4C-seq occupies a specific niche between the worlds of 3C-seq and 5C-seq. In the
former, a single primer pair is developed for a bait and target region whereas in the later, a
large set of primers are developed and analyzed relative to numerous interacting loci. 4CSeq however, probes the DNA-DNA interactions between a single bait or viewpoint primer
sequence and all the other regions of the genome with which this select sequence interacts;
thus, it is a considered a “one-vs-all” analysis, whereas 3C is considered “one-vs-one” and
5C is considers “many-vs-many” (Krijger et al., 2020).
By designing probes along the VZV genome, we can catch a glimpse of the
interactions that the virus genome is making with the host cell genome in three-dimensional
space. To identify these interactions during acute VZV infections, a cell model derived
from human fetal-lung fibroblasts was employed. These cells resemble the in-vivo
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fibroblasts which are the primary sites of entry for VZV infection; furthermore, these cells
have proven to be a tractable model for the study of VZV acute infection in-vitro. The
infecting VZV virus will establish successful replication in a subset of the cells and will
subsequently establish viral replication centers that are essentially factories for producing
and packaging new virions. Eventually, the cell will lyse and virions will be released into
the extracellular environment, allowing the infection to proliferate. These replication
centers take over the host nuclear space, pushing the host cell nuclear material to the
periphery of the nucleus. It is thus obvious that the infecting virus is reorganizing chromatin
to make room for the establishment of these replication centers within the nucleus.
The virus is likely taking advantage of the initial chromatin reorganization to
regulate host and viral gene transcription in a way that allows it to evade or downregulate
the host immune system as was discussed in chapter 1. The chromatin states and structures
involved with an acute VZV infection, as well as those of the latent and reactivated stages,
are not well understood. To begin to understand the complex chromatin biology regulating
the latent and reactivated stages of VZV, we must first gain a solid foothold in in our
attempts to traverse the biology of the acute infection. With a better understanding of the
acute stage VZV chromatin biology, researchers can then move to better understand latency
and reactivation – a condition that can lead to serious health conditions such as shingles,
severe neuralgia, and stroke (Depledge et al., 2018b).
Given that there is such a pressing need to understand how the latent virus so
effectively takes up residence in its host cells and reactivates later in life, causing
significant health complications, our study begins to answer vital questions pertaining to
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the role that chromatin biology plays in the establishment and maintenance of the acute
stages of the VZV life cycle.
To begin my investigations, the establishment of an acute, lytic infection in HFL
cells was first achieved and these infected cells were then assayed with 4C sequencing to
identify the host-virus interactions that comprise the higher order chromatin structures of
the infection, as well as to identify chromatin states associated with the acute infection. I
hypothesized that the host-virus interactions would be associated with open chromatin
during infection, contributing to a transcriptionally permissive environment for the acutely
infecting virus. Furthermore, chromatin immunoprecipitation sequencing (ChIP-Seq) was
performed for the ubiquitous transcription factor CTCF. Because CTCF has been identified
as a key player in the chromatin biology of other herpesviruses, as discussed in chapter 1,
it was hypothesized to be associated with the host-virus interactions, thus contributing to
the permissive chromatin state of the acute VZV infection.
Together, in this study I have employed genomics methodologies and cutting-edge
bioinformatics analyses to probe the hidden world of chromatin host-virus interactions.
The results obtained and discussion entertained herein shed new light on components of
the complex, elegant world of molecular virology. In turn, it is hoped that the biology that
I have begun to uncover will allow researchers to begin to better characterize the
transcriptional landscape regulated by these higher order chromatin structures . Such
insights could ultimately lead to the development of novel therapeutics, such as small
molecule inhibitors, that could either prevent VZV (or other HHV) infections from
successfully establishing latency, or at least prevent the virus from reactivating, reducing
the virus’ potential to contribute significantly to human disease morbidity.
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Varicella zoster virus (VZV) is a ubiquitous human pathogen to which >90% of the
world’s population has been exposed (Virgin et al., 2009). As an alphaherpesvirus, the
VZV life-cycle is characterized by lytic replication where all of the approximately 70 genes
are expressed (Cohrs et al., 2003; Nagel et al., 2011) and a latent stage where transcription
is limited to at a set of latency associated genes (Nagel et al., 2011; Depledge et al., 2018b).
Reactivation from latency, resulting in clinically significant disease, occurs with decline of
virus specific CD8+ T cell decline that occurs with aging and immunosuppressive disease
or therapy (Gershon et al., 2008). VZV is a highly cell associated virus and time course
analysis of virus transcription during one-step growth cannot be performed, but all
indications suggest VZV transcription mirrors herpes simplex virus type 1 (HSV-1) in that
virus gene expression follows a highly orchestrated process including immediate -early,
early, and late gene transcription (Wagner and DeLuca, 2013). However, like HSV-1, this
process is altered during virus reactivation where initial virus transcription is deregulated
and includes genes of all kinetic classes (Roizman et al., 2011; Kobayashi et al., 2012;
Wilson and Mohr, 2012).
Knowledge concerning the initiation of virus gene transcription during the
transition between latency and reactivation is critical to understanding the entire picture of
VZV reactivation. Promoters for VZV genes that are expressed during early stages of virus
reactivation contain histones with euchromatic post-translational marks (H3K9ac) that are
absent on histones that coat promoters for untranscribed genes (Gary et al., 2006). Such
findings support the overall hypothesis that host chromatin plays a key role in regulating
the VZV life cycle.
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To begin properly investigating the chromatin biology of the first, or acute stage,
of VZV infection, tractable cell models must be employed – i.e., models in which the
researcher has control over the stage of infection, and in which the cellular physiology must
mimic the in vivo physiology as much as possible. HFL cells are employed herein as their
physiology is similar to the dermal fibroblasts that are a common site of VZV entry, and
acute infection in these cells also mirrors some aspects of a latent in vivo infection as well
(as mentioned in chapter 1).
Within the nucleus of acutely infected cells, it is known that loops formed by
chromatin fibers are further looped into larger regulatory loops creating insulated
chromatin “neighborhoods”. Furthermore, groups of these regulatory loops can band
together to form topologically associated domains or TADs, introduced in chapter 1
(Mishra and Hawkins, 2017). TADs are typically 500KB to 1MB in size and it is currently
held that TADs are formed by the looping of long strands of DNA via anchor proteins such
as the CTCF–Cohesin complex, which also forms boundaries between TADs (Insulator
proteins like CTCF can also form barriers at the sub-TAD level as well). Gene expression
is primarily modulated within TADs by sub-TAD looping, but some gene regulation can
occur across TAD boundaries – called inter-TAD regulatory loops (at the meta-TAD level)
(Mishra and Hawkins, 2017). Groupings of similar TADs at the meta-TAD level form
chromosomal compartments commonly referred to as “A” or “B” compartments. A
compartments are associated with transcriptionally active euchromatin states, found
internally within the nucleus, whereas B compartments are associated with
transcriptionally silent or closed chromatin (typically lacking enrichment of significant
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histone modifications). B compartments are usually found at the periphery of the nucleus
whereas A tend to be found internally (Mishra and Hawkins, 2017).
The related Human alphaherpesvirus, HSV-1, contains CTCF binding sequences
that have been shown to play a role in regulating viral gene transcription and are thought
to play a role in transitions between HHV life cycle stages, e.g., a transition between an
acute and latent stage or between a latent and reactivated stage (Washington et al.). Thus,
I believe that it is reasonable to suspect that VZV also interacts with host CTCF. Such
interactions could result in phenomena like chromatin looping and/or anchoring that is
associated with TAD organization and thence gene expression. To test the hypothesis that
VZV higher order chromatin structure associates with CTCF during the acute stage of
infection, I first interrogated VZV-infected human fetal lung fibroblast (HFL) cells for the
presence of host-virus DNA interactions using 4C-Seq. I then mapped these interaction
sites to CTCF binding sites using ChIP-Seq. Taken together, the results from the above
experiments indicate that during acute VZV infection in the HFL cell model, VZV DNA
forms topologically linked loops with host DNA that are located near host CTCF binding
sites. Such looping likely plays a role in modulating host gene expression in a manner that
facilitates transitions between, or maintenance of, stages of the VZV life cycle.

Methods

Cell Lines and Virus
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Clonally expanded human fetal lung fibroblast cells (HFLs) (ATCC, Manassas, VA
infected with varicella zoster virus (VZV, Human alphaherpesvirus 3, strain Gilden;
GenBank: MH379685.1; https://www.ncbi.nlm.nih.gov/nuccore/MH379685.1) were
procured from the laboratory of Randall Cohrs at the University of Colorado Denver Anschutz Medical Campus and were propagated at the desired multiplicity of infection
(MOI) as described previously (Grose et al., 2013; Baird et al., 2014). Briefly, infected
HFL cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented
with 10% fetal bovine serum (FBS), 1% penicillin streptomycin (Pen/Strep), and 1% LGlutamine. All cells were maintained in 75 cm2 flasks (Sigma-Aldrich Corp.) as
monolayer cultures in a humidified 5% CO2 air incubator at 37°C. VZV infe ction
proceeded to an MOI equal to 1 × 10−3 cell-free VZV virions.

Confocal Microscopy

VZV-infected HFL cells were prepared in 24-well u-plates (ibidi, Martinsried, Germany)
described above. At 3 dpi, cells were fixed with 4% paraformaldehyde for 20 mins and
immunostained for the major VZV DNA binding protein ORF29. Briefly, cells were
permeabilized with 0.15% Triton-X, blocked in 10% normal donkey serum, incubated in
mouse anti-VZV ORF29 overnight at 4°C. The following day, secondary antibodies, Alexa
Fluor 488 donkey anti-mouse (1:500, Invitrogen), were applied for 2 hours followed by 2
ug/mL 4’, 6-diamidino-2-phenylindole (DAPI; Vector Labs) for 5 minutes. Cells were
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visualized by confocal microscopy (using a 3I Marianas inverted spinning disk on Zeiss
Axio observer Z1; Oberkochen, Germany) and analyzed using 3I Slidebook 6 software.

Chromatin Immunoprecipitation

The antibody used for ChIP-Seq experiments was polyclonal rabbit anti-Human
CTCF (D31H2) antibody (cat: 3418S from Cell Signaling). ChIP sequencing was
performed as described previously (O'Geen et al., 2011) on the VZV infected HFL cells.
For all immunoprecipitations, 20 ug of chromatin was incubated with 10 ul of antibody
overnight at 4°C. The complexes were precipitated with 20 ul of Protein G Magnetic Beads,
(Cat: 70024S Cell Signaling), followed by extensive washing, and final elution of the
immunoprecipitated chromatin complexes in 50 uL of ChIP elution buffer for subsequent
DNA purification and library construction. Libraries were prepared using the ThruPLEX
DNA-seq High Performance Library Preparation kit for Illumina NGS Platform following
the manufacturer’s instructions. Library DNA concentration and quality were assessed on
a Qubit 2.0 Fluorometer and an Agilent 2100 Bioanalyzer Instrument, respectively. Pooled
libraries were sequenced on an Illumina NovaSEQ 6000 instrument using paired end
sequencing at the University of Colorado Denver – Anschutz Medical Campus to obtain
5x10 million 101 bp reads per sample. Sequence reads were aligned to the human (hg38)
and VZV (NC_001348.1) genomes using Bowtie2 (Langmead and Salzberg, 2012). The
resulting SAM alignment files were used for peak calling using MACS2 against the control
(no antibody) inputs (Zhang et al., 2008) and using default parameters.
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4C-Seq library preparation and sequencing

VZV infected HFL cells were prepared as described above and 4C-seq libraries were
prepared according to methodology as described previously (van de Werken et al., 2012;
Krijger et al., 2020), using HindIII/DpnII restriction enzymes. VZV infected HFL cells
were cultured as described above and fixed with 1% formaldehyde prior to being snap
frozen. For each 4C library, ten million cells were used unless otherwise noted. Inverse
PCR was performed in 50 uL reactions using 200ng 3C library temp late, 25 uL Q5 Hot
Start High-Fidelity DNA Polymerase 2X Mastermix (New England Biolabs), 1.5 ul of
10uM forward and reverse inverse PCR primers and water under the following conditions:
30s 98°C, 10s 98°C, 30s 55°C, 2m 72°C, 5m 72°C for a total of 25 cycles. PCR products
were cleaned up using the PCR purification kit (Thermofisher Scientific) using the B3
reagent to exclude fragments less than 300 base pairs or with Ampure XP beads (Beckman
Coulter) and eluted in water. Library indexing was performed using the DNA HT Dual
Index Kit (Illumina) or with custom dual indexing primers with an additional 8 cycles of
PCR. All primers sequences are listed in Supplemental Table 4. Libraries were pooled and
sequenced on an Illumina HiSeq2500 at the Vermont Integrative Genomics (VIGR) Core
Facility at the University of Vermont.

4C-Seq primer design
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Our

previously

designed

4C-Seq

primer

design

tool

(https://github.com/FrietzeLabUVM/4c_primer), which was developed in-house to
facilitate the creation and generation of the inverse PCR primers necessary for 4C-Seq
library generation, was employed here along with Primer-Blast (primer3) (Rozen and
Skaletsky, 2000; Ye et al., 2012) to develop the inverse PCR primers. A fasta file
containing the reference genome of interest (RefSeq: NC_001348.1), from which the
viewpoint primers were chosen, was uploaded into the interactive tool. Then the restriction
endonucleases of choice (HindIII and DpnII) were selected. Finally, the minimum
fragment sizes following the first and second rounds of digestion were selected using the
sliding bars. A minimum size of 500 bp for the first fragment and 300 bp for the second
fragment were selected as parameters for our experiments (van de Werken et al., 2012).

4C-Seq analysis

4C-seq trans interactions were determined using a “window” method as described by Kim
et al. (Kim et al., 2020). The virus viewpoint regions at the beginning of the reads were
trimmed off using Cutadapt (Martin) software and the remaining human portions were
aligned to the human UCSC hg38 reference genome using bowtie2 (version 2.3.5)
(Langmead et al., 2009; Langmead and Salzberg, 2012). P-values for each mapped base
were then calculated for each 10kb window across all chromosomes using a Poisson
formula. At the end, significant peak regions are filtered using MACS2 (version 2.2.7)
bdgpeakcall function (Zhang et al., 2008). Significant interacting trans peak regions were
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identified using the above window method for each replicate and for all four viewpoint
regions. These regions were plotted as circos plots using the Circlize R library (Gu et al.,
2014). Bedtools (Quinlan and Hall, 2010) was used to find the intersection of the trans
regions and the IMR90 25-state imputation-based chromatin state model created with
ChromImpute (Ernst and Kellis, 2012; Ernst and Kellis, 2015) and made available from
the Wang Lab (Jin Wook Lee). 4C trans peaks and signals were also compared to CTCF
ChIP-Seq peak results identified using in-house scripts along with the programs Bowtie2
and MACS2. 4C-seq cis interactions were determined using the program peakC (Geeven
et al., 2018). Finally, publicly available IMR90 HiC compartment call data (Fortin and
Hansen, 2015) and IMR90 TAD boundary data (Akdemir and Chin, 2015) were used to
identify which regions of the overlapping 4C trans peaks and CTCF ChIP-Seq peaks
overlapped with which regions of open and closed chromatin, along with TAD boundary
regions. HiC plotter (Akdemir and Chin, 2015) was used to visualize the HiC expression
matrices and contact maps relative to the 4C-Seq and ChIP-Seq peaks.

Results

Establishment of acute VZV infection and 4C sequencing results

Latent VZV infection was successfully established in vitro using HFL cells. Successful
acute infection was confirmed via confocal scanning laser microscopy. The acute, lytic
VZV infection evidences discrete replication centers within the host cell nucleus which are
readily visibly with the confocal scanning laser microscopy upon treatment of samples with
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green florescent probes for the ORF-29 VZV major DNA binding protein region (Fig.
3.1.A-B). Viewpoint primers were successful generated against the VZV genome (Fig.
3.1.C.) and 4C-Seq libraries were constructed. The data returned after sequencing was
aligned to the UCSC hg38 reference genome and produced signal across regions of the host
cell chromosomes indicating the successful capture of higher order chromatin contact
points between the virus and the host cell nucleus (Fig. 3.1.D).

Higher order chromatin interactions reveal transcriptionally permissive states

The significant 4C trans peaks that were concordant across replicates showed some
overlap between viewpoints (Fig. 3.2.A), with a total of 334 peaks concordant across all
four viewpoints (Fig. 3.2.B). When annotated with chromatin states that were determined
using databases of publicly available IMR90 data along with the software chromHMM and
ChromImpute (Ernst and Kellis, 2015), heterochromatin states were less enriched than
others. Hierarchical clustering followed by K-means clustering confirmed the
heterochromatin states were the least enriched in the high confidence 4C peaks as can be
seen at the far right of cluster 3 - large purple box (Fig. 3.2.C and 3.2.D).

Virus-host contact regions overlap with CTCF sites which are in turn localized
around TAD boundaries.
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Chromosome 12 harbored the highest number of significant 4C peaks (Fig. 3.3.A.
and Fig. 3.3.B). The HiC contact maps that are shown in the top two panels demonstrate
that regions of the host chromosome that are closer to one another are more likely to
interact. The 4C and CTCF peaks – center panels – demonstrate that these peaks are found
across the genome but tend to cluster with the CTCF peaks, which themselves are more
concentrated near the TAD boundaries (the peripheries of the TADs). The right panel
shows a zoom-in on chr12:48,000,000-58,00,000 where it is more easily seen that the
CTCF peaks concentrate on the periphery of the TAD boundaries (bottom panel). The
distribution of 4C peaks is not as limited to these peripheries but there is overlap between
the 4C peaks and the CTCF regions as hypothesized.

CTCF and virus-host interactions are significantly associated with one another and
are enriched in open, infected chromatin.

Fig. 3.4.A and Fig. 3.4.B show the overlap between 4C peaks, CTCF ChIP peaks
and open and closed regions of IMR90 chromatin. In both cases there are more CTCF and
4C peaks overlapping with open regions of the genome than with closed regions. But most
importantly, there is a significant difference between the number of 4C/CTCF colocalized
peaks in the infected data relative to the mock data, and this difference is not present when
comparing CTCF and closed region overlaps between mock and infected data or when
comparing CTCF open and closed regions in the infected data. Fig. 3.2.C. Taken together,
these results indicate that CTCF and virus-host 4C peaks are colocalizing to a significantly
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greater degree in the infected data vs the mock, and this is not seen when looking at CTCF
alone with regard to either infection status or open/closed chromatin status. Thus, we can
deduce that the significant CTCF and 4C-Seq host-virus interactions are significantly
associated in the open chromatin regions of the infected samples.
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Figure 3.1. HFL cells provide a tractable model to study VZV acute infection in vitro.
Fig. 3.1.A Surface image of confocal scanning microscopy imaging of HFL nuclei acutely
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infected with VZV. Stained with DAPI (blue) and the major VZV DNA-binding protein
ORF29 (Gerstein et al.). Fig. 3.2.B. Three-dimensional reconstruction of scanning confocal
laser microscopy images of acutely infected HFL cells (nucleus: DAPI, blue; VZV
replications centers, green). Fig 3.2.C. The VZV genome presented visually as a circos
plot, with the locations of the four viral viewpoints relative to the VZV genome. Fig 3.2.D.
4C-Seq signal for all replicates and viewpoints across the viral genome faceted by
chromosome, demonstrating successful 4C-Seq library preparation and sequencing results.
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Figure 3.2. High confidence 4C-Seq trans interactions and chromatin state
annotation. Fig 3.2.A. binary heatmap of the overlapping peaks by viewpoint. The y-axis
represents significant peak regions overlapping across replicates. Overlaps of the overlaps
can be seen by identifying the regions of the heatmap “black” that overlap between
viewpoints. The 334 peaks that overlap across the viewpoints (VP1-VP4) are shown as a
circos plot in Fig. 3.2.B. The acutely infecting VZV genomes make contact points with
multiple chromosomes, with denser regions indicating “hotspots” of interaction activity.
Fig. 3.2.C-D. The 334 identified most significant 4C peaks annotated with chromatin state
information from publicly available IMR90 data. Hierarchical clustering dendrogram (top
tree) was applied to the number of annotations for the different chromatin states (x -axis)
followed by k-means clustering – colored boxes, identifying heterochromatin states – far
right of the center purple box, as the least enriched states associated with the 4C -Seq
regions.
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Figure 3.3. Visualization of the higher order chromatin structures of VZV with the
host cell genome. Fig. 3.3.A. Interaction matrix of IMR90 data across chromosome 12.
Both square and triangular representations demonstrate the organization of the host genome
into TADs. CTCF peaks, as expected, are concentrated more to the periphery of TADs and
4C-Seq peaks are overlapping with numerous CTCF ChIP-Seq peaks. Fig. 3.3.B. Zoom in
on regions chr12:48,000,000-58,000,000. Again, we see CTCF peaks more to the periphery
of TAD boundaries with CTCF peaks within the vicinity.
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Figure 3.4. CTCF is associated with host-virus contact points in open chromatin
regions. Fig. 3.4.A. There are more overlaps with CTCF and 4C-Seq regions in open
chromatin regions in the mock data. Fig. 3.4.B. A similar pattern is observed for the
overlaps in the infected data. Fig. 3.4.C. There is a significant difference between mock
and infected peaks (left bar). The infected overlap counts from the Venn diagrams in Fig.
3.4.B were then scaled up so that the relative proportion of mock and infected overlaps
were equal for the three subsequent comparisons. Most importantly, the CTCF-4C-open
chromatin overlapping regions are significantly increased in the infected data relative to
CTCF-4C-open chromatin regions in the mock data (middle-left bar); however, there is not
a significant difference between CTCF-4C-closed chromatin overlapping regions in mock
vs. infected data (middle-right bar). Finally, there is no significant difference between
CTCF-open chromatin overlaps in the mock vs. infected data (right bar).

Discussion

Here I employ human fetal lung fibroblast (HFL) cells infected with VZV, along
with unbiased epigenomic profiling methods to identify higher order chromatin structures
and chromatin states present in the acutely infected samples. I identified both virus-host
contacts (trans) interactions as well as virus-virus (cis) (Appendix B-1, supplemental
figure 3.1) interactions using a variety of bioinformatic and statistical methods applied to
our 4C-sequencing results. Trans interactions were found to correspond preponderantly to
open chromatin regions within topologically associated domains or TADs. I also performed
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ChIP-Seq for the transcription factor CTCF – known to play a role in maintenance of
alphaherpesvirus life-cycle stage. The acute chromatin states of the host-virus interactions
were found to be “permissive” rather than “silencing” (Fig. 3.2), and perhaps most
importantly, I identified a significant association between virus-host contact regions (4CSeq regions) and CTCF peak regions in open chromatin in infected data relative to
uninfected (mock) data (Fig. 3.4). This association suggests that CTCF plays a role in
mediating the higher order chromatin structures of the host-virus interactions during an
acute infection. This finding hints at the potential presence of a CTCF-mediated host-virus
structural mechanism at play in the acute infection. It remains to be shown if such a
mechanism, akin to the tethering mechanism in gammaherpesviruses such as EBV, is
indeed present at time points during any or all of the alphaherpesvirus (VZV and HSV-1,
etc.) life cycle stages.
The results from these experiments, provide an in-depth characterization of the
higher order chromatin interactions of VZV with the human host genome that occur during
acute VZV infection. While studies with giardia gels, which separate out large molecules,
found that HSV-1 was not found to be associated covalently with any chromatin in its latent
state, it is known that the ends of the latent virus are fused together covalently as an
episome, and the same is the case with VZV. Thus, a CTCF-cohesin tether is possible, but
there is no essential requirement that this be the case. Unlike with EBV, where the virus
maintains a tether to the host genome in order to successfully replicate and equally partition
its genome into daughter cells, neurons don’t replicate (generally speaking) so the
neurotropic alphaherpesviruses like HSV-1 and VZV do not need to be concerned with the
partitioning of their latent genome during host cell replication. So, there appears to be no
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essential need for a tether at the acute (or any other) stage of VZV infection in the manner
of the gammaherpesvirus infection. But it has also been hard, until recently, to gather
enough latent material from cell, animal, and human samples to adequately address this
issue during the latent state. The recent arrival of the LUHMES cell model of infection for
HSV-1 and the HD10.6 cell model of infection for VZV will allow us to collect enough
genomic material to adequately settle the question of CTCF-cohesin tethering in
alphaherpesviruses once and for all. In addition, it is possible that some degree of tethering
happens in acute alphaherpesvirus infection, simply due to the nature of the host-virus
interactions, but there is no end achieved through this tethering as the cell does not live
very long before succumbing to infection.
Regardless of whether viral tethering during acute (or latent/reactivation) VZV
infection exists, and has a distinct biological purpose or not, I have demonstrated that we
can identify the sites of host-virus interactions during acute infection and that there does
appear to be evidence indicating that CTCF is associated with these higher order chromatin
structures. This important finding goes against the current status quo in the
alphaherpesvirus field. The methodology developed here should be applied to the newer,
and more comprehensive, HD10.6 cell model of VZV infection in future studies. With the
proper techniques and cell models in place, and with the results herein hinting at the
presence of a CTCF-related structural mechanism involved in acute VZV infection, we can
soon establish whether tethering exists at the various stages of the alphaherpesvirus life
cycle. Such findings will provide much deeper insight into the chromatin structure and
states, particularly with regards to CTCF, that contribute to regulation of the VZV life
cycle.
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CHAPTER 4

Discussion

Chromatin is an essential part of the herpesvirus life cycle. Host-virus chromatin
interactions, as well as the recruitment of chromatin modifying enzymes and the epigenetic
and genetic pathways involved, work in a concerted manner to establish, maintain, and
regulate the transition of the herpesvirus life cycle (Kennedy et al., 2015). Furthermore, a
variety of cell and animal models are being investigated in which to study the ho st and
cellular factors regulating the herpesvirus life cycle across different tissues and over time.
As was discussed in chapter 1 and reemphasized via the results in the main body of this
dissertation, there is growing evidence of to support the role of chromatin factors playing
a role in regulating the herpesvirus life cycle across various tissue types, physiological
conditions and across specific viruses (Yalcin, 2012).
While there are sub-families of Human herpesviruses, they all share similarities,
and harbor their own unique characteristics with which they have coevolved with their
hosts over hundreds of millions of years (Aswad et al., 2020). For example, the unique
portions of each species’ genome contains both conserved genes and gene cluster unique
to each viral species (Wang et al., 2020). In addition, the different HHVs contain varying
types and numbers of repetitive regions of their respective genomes. In the case of HHV6 (A and B) the repetitive regions at the end of the genomes are known to be necessary for
integration and the establishment of latency; whereas, with other regions, ORFs are
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contained therein such as with VZV ORF4 (Wang et al., 2020), and for some repetitive
regions, the function remains unknown.
In this dissertation I focused on the role that chromatin biology plays in two
separate HHVs at two separate life cycle stages in relevant cell models. In chapter 2 I
presented my work on latent HHV-6A infection before proceeding to discuss my
experimental findings with regards to acute VZV infection in chapter 3. Both viruses are
relatively less well characterized, in terms of their chromatin biology, than the
gammaherpesvirus EBV and the alphaherpesvirus HSV-1, about which we have the most
comprehensive understanding of the role of chromatin structure and function in
establishing and maintaining the various HHV life cycle stages.
I successfully investigated the chromatin biology of two HHV-6 cell models of
infection in chapter 2: the in vitro-derived HEK29T cell lines infected with recombinant
HHV-6A (ciHHV-6A), as well as a cell line derived from the umbilical arterial smooth
muscle cells of patients with inherited chromosomally integrated HHV-6A infection
(iciHHV-6A). These two cell models, although somewhat limited, remain the best cell
models that we have for studying the HHV-6A life cycle. Cells that are more
physiologically relevant to the HHV-6A latent cell tropism such as J-Jhan cells, have not
been capable of sustaining a latent infection in-vitro. Primary cells - such as lymphocytes
isolated from iciHHV-6A positive patients, are of course useful in that they contain the
physiologically relevant cellular environment found in an actual infection, but they do not
present the researcher with the ability to regulate the transition between the different HHV6A life cycles stages.
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The ciHHV-6A cells establish latency over a time course as shown using RNA-Seq
in chapter 2. Our lab had previously demonstrated that the genome would also reactivate
with the administration of the phorbol ester TPA, although only GFP was transcribed
(Saviola et al.). This is the main disadvantage of the ciHHV-6A cell model. The model was
initially demonstrated as capable of full reactivation of the virus genome by Arbuckle et
al. (Arbuckle et al., 2010), but attempts to replicate these findings have not been successful
by other researchers. The reactivation potential is somewhat unstable and may itself be
subject to degradation over time with increasing cell passage number or the accumulation
of mutations that render the chromatin states that we seek to investigate unstable and
further removed from the in vivo scenario. This should highlight to the reader the difficulty
in developing tractable in vitro models for studying the HHV life cycle. With that caveat
in mind, the ciHHV-6A cell model nonetheless represents a notable achievement towards
the development of tractable cell models to study HHV-6 infections.
To assay the chromatin landscape surrounding the latent, integrated HHV-6A virus
I chose to employ 4C-Seq because the small size of the viral genome allows a
comprehensive picture of three-dimensional host-virus interactions to be painted with a
relatively small number of viewpoint regions. However, even though software was
available for generic 4C analysis, i.e., analyses utilizing human viewpoint regions, I learned
after trial and error that the current 4C software, for the most part, is not suitable to assaying
virus host interactions. This is because most software expects the viewpoint region to be
on a human chromosome. Thus current methods had to be modified to take into account
the presence of an exogenous chromosome, such as an infecting HHV genome.
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Eventually, I found that a recently published method developed in Paul
Lieberman’s lab by Kim et al. (Kim et al., 2020) allowed for the most flexibility for
assaying 4C interactions within the constraints of our experiments and offered the best
resolution of identified significant 4C peaks. However, the statistical and computational
methodology was only briefly discussed in their publication, and was not published as a
stand-alone software, and neither was, to my knowledge, the computer code. Thus, I had
to elucidate how the p-value equation that they outline in their paper was detailing how to
calculate a probability for each nucleotide in every chromosome in each 4C sample. I
believe this scenario emphasizes the importance of technological proficiency as virology
enters the genomics era. Methods have always driven science in my opinion and
computational genomics is rapidly becoming a powerful tool for biological discovery and
such methodology is in most cases not simply “push button”. The genomics researcher will
need to have more than a superficial knowledge of biology, computer science, and statistics
simultaneously, in order to make the most out of these powerful new techniques.
I showed in chapter 2 that both the Illumina and Nanopore platforms produced
similar results, and with the increasing accuracy of long read Nanopore technology,
coupled with its inexpensive costs, I believe this will become an increasingly popular
sequencing alternative in the future relative to the more traditional sequencing systems.
But the more established systems such as Illumina still provide greater base pair resolution
(Wang et al., 2020) and read depth at the time of writing. In the case of VZV acute
infection, where we have many copies of the viral genome in a single infected nucleus, the
added resolution of the traditional Illumina system is still preferable.
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I will again emphasize that is was because of the increasingly powerful techniques
available to the genomics researcher that I was able to develop and apply my novel 4C-Seq
framework to interrogate the higher order chromatin structure of HHV-6A. This work
builds off the previous findings to which I contributed where we showed via ChIP-Seq
experiments, and bioinformatics techniques, that the repressive histone marks H3K9me3
and H3K27me3 were broadly enriched across the latent HHV-6A genome (Saviola et al.,
2019a). I was able to build on this foundational work and create an innovative and
reproducible method for utilizing 4C sequencing data to statistically rank the chromosome
ends in terms of their probability for harboring an integrated HHV-6A genome.
As discussed in chapter 2, the integrated chromosome technically represents a “cistrans” event because we are looking for virus-host interactions (trans) on the chromosome
of which the virus is now a part via integration (cis). Because cis interaction signal tends
to drop off monotonically across approximately 1 MBp, and because the sub-telomeric
regions are approximately 500kb in size (2014 genome biology reference), 500 KBp was
chosen as the size with which to compare the chromosome ends. I developed an algorithm
to score the reads that were closest in proximity to each other, and these scores could then
be evaluated with the aforementioned statistical ranking system.
In fact, the parameters chosen for the above computational components themselves
could be refined in computational experiments potentially leading to further improvements
in the detection capabilities of my methodology. I mention this fact because I believe that
it is important to remember that computational experiments, such as parameter sweeps, are
in themselves scientific experiments in which a hypothesis is generated, tested, and
evaluated within a framework of rational empiricism and falsifiability.
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With the parameters that I currently use, it was seen in chapter 2 that across
viewpoints and replicates, chromosome 15q was identified in ciHHV-6A cells as the prime
candidate for integration by far. While chrom15q has not yet been widely reported as a site
of integration for the HHV-6A virus, studies on a population level have only just begun
(Aswad et al., 2020). Another strong possibility is that the end of chromosome 15q
underwent a translocation event, either pre- or post-viral integration, leading to a
recombinant chromosome harboring HHV-6A integrated at the end of one arm of its
chromosome. Interestingly, there is recent evidence in the literature for such translocation
events in 293 cells identified via molecular cytogenetics techniques (Binz et al., 2019). A
future study utilizing a three-probe fish: one for virus, one for original chromosome, and
one for secondary chromosome, could be used to confirm whether a translocation event
has occurred in the chromosome harboring the integrated HHV-6A virus.
Turning our attention to the iciHHV-6A cell samples, it was clear both from my
4C-Seq workflow (from library building through computational genomics analyses and
FISH confirmation) that chromosome 19q harbored the integrated virus. Interestingly,
chromosome 19q has been reported as a site of integration across numerous collated studies
confirmed via FISH (Aswad et al., 2020). While there does not yet appear to be a clear
pattern as to a specific chromosome preference in which the virus will integrate, the
application of novel computational methods to high-throughput data, coupled with
improving bioinformatics methods for data collation and mining, will allow researchers to
more easily answer questions such as “is there a chromosomal preference for integration
across HHV-6A strains and across human and cell populations?”
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In chapter 2 we saw that the integrated virus made few interactions with other
chromosomes. The few “trans” interactions that it did make were found to be associated
with “quiescent” and “heterochromatin” annotations along with some weaker evidence for
some enhancer and transcription factor activity. Because quiescent regions were most
associated and because the latent virus is itself transcriptionally quiescent, it makes sense
that HHV-6A has evolved its integration site preference based not only on its ability to
undergo homologous recombination with the canonical mammalian repeat regions
(TTAGGG)n of the subtelomeric region, but also because this is an overall transcriptionally
quiet region of the host genome. Thus, the virus is disrupting the host transcriptional
machinery weakly if at all, disruptions which could signal intracellular stress responses
that might jeopardize its survival.
Additionally, the heterochromatin annotation accords well with the previous studies
showing chromatinization of the HHV-6A genome with repressive histone marks (Saviola
et al., 2019a). Here, further evidence is provided that HHV-6A is heavily chromatinized
during its latent state, contributing to the evidence that chromatinization, or the deposition
of heterochromatin along the virus genome, is rendering the virus transcriptionally
quiescent during latency. A finding that corroborates the role of chromatinization patterns
in HHV life cycle regulation that has been discovered in other HHVs (as discussed in
chapter 1). One major outstanding question is how this chromatinization is established in
the first place.
Future studies should focus on reproducing the trans interactions that were
identified and striving to improve the resolution of said interactions. While it appears likely
that the virus does not want to disrupt the host cell transcriptional machinery too much,
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which again may give away its presence to the cell, confirmation or identification of
additional trans regions can be compared and contrasted with studies from acute infections
to identify regulatory regions, specific genes and/or pathways that are c ommon between
the two life cycle stages, or that at least point researchers towards possible mechanistic
bridges between the two stages. Thus, an excellent next step would be to consider
chromatin conformation assays such as 4C-Seq across a time course spanning acute to
latent stages of infection: ~1 to 7 days. Such a study could be combined with RNA-seq
data in a “systems biology” approach to identify associations between higher order
chromatin structures and gene regulation. Gene products or regulatory regions implicated
in the transition could then be probed via knockdown or targeted deletion to confirm
whether these factors play an essentially role to the life cycle transition.
Overall, the process of uncovering the mechanisms governing the establishment
and maintenance of both acute and latent HHV-6A infections, as well as the mechanisms
that control reactivation of the latent virus is an ongoing and challenging endeavor.
Employing both cell models of primary infections and patient samples, I have developed
methodology that utilizes unbiased epigenomic profiling methods to identify the site of
HHV-6A integration within the host genome and to assess the higher order chromatin
structures of which it is part. I have then used this information along with data from other
epigenomic profiling methods, such as MNase and ChIP-seq to more fully characterize the
chromatin state of the latent HHV-6A virus in multiple cell models of infection as well as
in primary patient cells. Such methodology provides a high-throughput means to
uncovering the higher-order host-virus chromatin biology hypothesized to regulate the
virus life cycle and contributes to the groundwork for the application of these technologies
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to the realm of clinical diagnostics, e.g., for screening transplant recipients for the presence
of HHV-6 integration.
To summarize, in chapter two I: 1.) demonstrated the validity of the best current
“controlled” cell model for studying the chromatin biology of HHV-6, 2.) established a
novel high-throughput methodology for assaying higher order chromatin structure in cells
infected with HHVs, and 3.) Contributed to the current understanding of the overall
chromatin landscape (structure and state) of latent, integrated HHV-6A in these cells, as
well as in patient-derived iciHHV-6A cells, and in lymphocyte cells harboring integrated
HHV-6A harvested directly from patients.
With the methodology worked out for HHV-6A, I was then able to apply the same
techniques to the study of the higher order chromatin structures and chromatin states of
acute VZV infection in HFL cells. This information could then be applied along with CTCF
ChIP sequencing results and computational methods in a systems biology approach to gain
insight into the role that CTCF is playing in acute VZV infection.
In terms of cell models, as discussed in chapter 1, some past initial success was
obtained with the use of human fetal fibroblast lung (HFL) cells, which are similar
physiologically to the dermal fibroblasts that are a primary infection site for VZV. These
cells are also able to recapitulate some elements of in vivo neural latency transcription
patterns, but the establishment of true latency, and reactivation therefrom, is not possible
in this cell model. Again, many cells are capable of infection with VZV in-vivo, ex-vivo,
and in-vitro, but the creation of a viable cell model in which the researcher can control the
life cycle stage of the infection has only been realized recently in the HD10.6 cell model
of infection (Thellman et al., 2017). This cell model derived from dorsal root ganglion cells
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is to date the best model for studying the HHV life cycle and the pertinent chromatin
biology in vivo. Thus, future studies utilizing the epigenomics and systems biology
approaches employed in this dissertation will likely lead to even greater breakthroughs in
our understanding of the role the host chromatin plays at all stages of the VZV life cycle,
in a more physiologically relevant environment.
It is known for example that during acute infection HSV-1 phosphatidylinositol 3kinase (PI3K) signaling proceeds through protein kinase B or AKT. One suc h pathway
involved mTOR complex 1 (mTORC01 - mammalian target of rapamycin), which
mediates the hyper phosphorylation of 4E-binding protein (4E-BP) which can mediate capdependent translation. NGF in turn can maintain latency through activation of mTORC-1
and its removal can lead to reactivation (Camarena et al., 2010; Kobayashi et al., 2012;
Kennedy et al., 2015). In the new HD10.6 cells, NGF depletion leads to reactivation as is
the case above for HSV-1 (Thellman et al., 2017).
For my work with HFL cells, efforts were focused on using 4C sequencing to begin
uncovering the host-virus chromatin interactions during acute infection. 4C sequencing has
been applied to numerous viruses including EBV and HIV, and the “higher C” studies are
becoming more and more common in general. Whereas 3C-Seq allows the researcher to
identify interactions that appear between a viewpoint or bait region and a single target
region (one vs. one), and 5C allows numerous bait regions to be assay relative to the entire
genome (all vs. all), 4C provides a flexible middle ground in terms of both
comprehensiveness and specificity. We can choose a particular viral region of interest –
the viewpoint(s) – and design primers against this region. Upon inverse PCR we can create
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amplicons that can then be sequenced via high throughput sequencing platforms and from
the sequencing data we can identify the host-virus trans interactions.
When the trans peaks that were identified as concordant across replicates and
viewpoints, were then annotated with chromatin state models developed using chromHMM
(Ernst and Kellis, 2012) along with the 127 genomes from the roadmap epigenomics
project (Wang et al., 2020), various chromatin states were found to be associated with these
contact regions. The annotations were of permissive chromatin states associated with the
open chromatin that was hypothesized and confirmed to harbor the virus-host interactions.
The heterochromatin state was among the least enriched – the opposite of what was seen
for the transcriptionally repressed, latent HHV-6A infection. Not surprisingly, there was
also some enhancer and transcription factor chromatin state annotation with the VZV acute
infection, providing further evidence that the virus is coordinating with open regions of the
host genome involved in transcriptional activation.
Furthermore, I also identified particular regions of CTCF ChIP-Seq peaks that
were concordant across replicates, which were in turn concordant with the VZV 4C peaks
shared across replicates. Thus, I was able to identify a number of high-confidence infected
4C and CTCF ChIP peaks that colocalized along the host genome. This is an important
finding for a few reasons. First, as discussed in the literature review in the introduction,
CTCF has been identified as a key component of the CTCF-cohesin complex coordinating
three-dimensional host virus chromatin architecture in Human gammaherpesviruses.
Second, CTCF has been identified as a key insulator protein in both Human gamma
herpesviruses and alphaherpesvirus such as HSV-1, where it has been shown to spatially
divide the virus genome into transcriptional competent and quiescent regions. Finally,
110

CTCF is known to coordinate chromatin boundaries and the establishment of topologically
associated domains via looping (Wang et al., 2020). Thus, the CTCF and 4C interactions
indicate that CTCF is also playing a role in the chromatin biology of acute VZV infection.
It is thus becoming apparent that not only is CTCF a critical transcription factor
and chromatin organizer in uninfected cells and plays a key role in the more distantly
related gammaherpesviruses and the more closely related HSV-1, but that it is also an
important chromatin factor in the VZV life cycle, possibly working to organize chromatin
during acute infection in order to regulate VZV transcription and subsequently the viral
life cycle.
Future studies could also look at differential CTCF occupancy between infected
and uninfected samples as well as Differential RNA sequencing between mock and
infected samples. The subsequent genes and pathways identified could reveal several genes
and signaling pathways that are differentially regulated between conditions and such
signaling pathways are thought to work in concert with epigenetic alterations to facilitate
the establishment of infection and ultimately latency (Kennedy et al., 2015).
Another genomics approach to unravelling the role of host chromatin in the acute
infection is to look at the differential occupancy between mock and infected cells and
compare this to both the 4C-Seq results from the infected data as well as the differential
RNA-Seq results. As mentioned earlier, CTCF has many roles in the uninfected and
infected host cell biology, and alterations in the position or frequency of CTCF occupation
between mock and infected samples can indicate how CTCF is dynamically changing
across conditions, potentially contributing to virus life cycle regulation.
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The identification of specific genes and promoters that are in the vicinity of
differentially occupied CTCF sites could provide us with likely candidates for genes
involved in the infection response and these genes are potentially coopted by the virus to
aid in the regulation of its life cycle. The top differentially occupied CTCF regions could
be investigated for overlap with the promoters of differentially expressed genes from an
RNA-Seq study. Significant genes identified in more than one experiment (including genes
with promoters proximal to identified 4C and/or CTCF sites) could be run through pathway
analysis algorithms to confirm inflammation response pathways due to infection as well as
to identify possible signaling pathways relevant to chromatin organization and function.
The above concordance between various chromatin-based assays and differential
transcription assays would shed light on the role that chromatin dynamics play in
fundamentally altering the host nuclear transcriptional and regulatory landscape. Genes
and pathways identified could be corroborated in literature and the identification of novel
markers serve as excellent seed points for the generation o f subsequent hypotheses
pertaining to the interplay of chromatin biology and the host transcriptional regulatory
pathways involved in the HHV life cycle. As such, future studies will need to proceed
further towards molecular confirmation of the key gene markers identified by such studies,
to provide assurance that the pathways identified and corroborated are indeed significant
to the biology under consideration. Such assurance will allow us to confidently decipher
which markers involved in the pathways are most relevant to the chromatin component of
the underlying acute stage HHV biology.
To summarize the VZV component of my work, I have obtained novel findings
pertaining to the higher order chromatin structures and chromatin states involved in the
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acute VZV life cycle stage. Such information contributes to building a secure foundation
for our understanding of VZV chromatin biology. Researchers can build on this foundation
by continuing to refine the cell models and methodology discussed herein and then carrying
out novel experiments aimed at building a complete picture of the role that chromatin plays
in the VZV life cycle.
The immediate and exciting next steps would be to transfer our experimental and
virological knowledge from the less physiologically relevant, but hitherto more tractable,
HFL cell model, to the new DRG-derived HD10.6 cell model of VZV infection. We also
have autopsied samples of trigeminal ganglia from patient donors to interrogate as well.
We can apply the same high-throughput methodology that I have developed to answer the
same and similar hypothesis that I discussed in chapter 3 relating to chromatin and the VZV
life cycle. With the proper methods and cell models in place, and insights from the results
that we have obtained thus far, we are certain to make exciting and far-reaching discoveries
into the mechanisms regulating the VZV life cycle in the human host.
Through the course of this work, I have successfully developed and employed high
throughput methodology and computational genomics techniques to gain further
understanding of the higher order chromatin structure and chromatin states in two viable
cell models for studying HHV-6A and VZV: two herpesviruses about which much of the
chromatin biology remains a mystery.
Thus, both VZV and HHV-6A are two HHVs about which much headway needed
to be made in terms of uncovering the role that chromatin biology plays in regulating their
respective life cycles. Due to the rapidly accelerating advances in high-throughput
genomics techniques, hardware, and chemistry in recent decades, coupled with
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concomitant advances in both software availability and computational resources, I was in
an excellent position to adapt these methodologies to the study of chromatin biology in
these two herpesviruses about which little was known.
It should again be emphasized that new methods developed herein will contribute
to the foundation for the application of ever improving and evolving high -throughput
sequencing technologies to uncover the complex interplay of nuclear replicating viruses
within their host cells. Such methods will almost assuredly lead to faster, more precise
methods for uncovering chromatin biology during HHV infection, as well as lend
themselves to improved clinical methodology.
During the Course of my work, I was able to implement and further characterize
existing cell models, both in vitro-derived and patient-derived, as model systems in which
to develop and apply my innovative computational genomics methods in order to assay the
higher order chromatin structures between of HHV infection, as well as add to the growing
body of literature pertaining to the role that host chromatin structure and states play in
coordinating and maintaining the HHV life cycle stages.
Furthermore, methodological developments such as the ones that I present herein,
can lead to the development of new fast, accurate, and cost-effective methodology for
identifying individuals that have iciHHV-6A infection. This would be an important
milestone in allowing clinicians to more effectively pre-screen and triage transplant
recipients that may harbor HHV-6A infection effectively prior to undergoing surgery.
It is my hope that other herpes virologists will be able to incorporate my findings
into their own work as well as draw upon and improve the methodology that I have
developed. We all seek to build upon the understanding of chromatin biology to which I
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have contributed that will ultimately lead to a complete picture of the precise role(s) that
host chromatin plays in regulating the HHV life cycle. It is my hope that soon the elusive
cellular mechanisms that govern the acute, latent, and reactivation stages of HHV infection
will finally be uncovered in cell models that adequately capture the in vivo human
physiology.
Only through a thorough understanding of the chromatin biology of HHV infection
will we gain a complete picture of the mechanisms regulating the life cycle of these
tenacious and troublesome viruses. Thus, with a thorough understanding of host cell
chromatin biology we will be able to piece together a complete model to explain the
mechanisms and structures involved in the establishment and maintenance of, as well as
the transition between, the various stages of the HHV life cycle. In future studies, we will
seek to further elucidate the higher-order chromatin structures and chromatin states of
HHV infection and how these chromatin factors work with other host and viral factors to
precisely regulate said life cycle stages.
With this knowledge, scientists and physicians can work to identify novel
therapeutic targets for which treatments can be developed to effectively treat HHV
infection at various the various life cycle stages. Ideally, efficient and precise ways of
eradicating the latent virus from its in vivo latent reservoirs could be identified as well. As
mentioned at the beginning of this work, the word “herpes” relates to this pathogen’s ability
to stealthily creep along throughout the human body well after resolution of the initial
infection. Through persistent hard work, professional interdisciplinary cooperation,
intellectual rigor, and the thrill of scientific endeavor, I believe that humanity will be able
to eradicate these insidious viral infections for good.
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APPENDICES

Appendix A-1: Supplemental Figure 2.1. HHV-6A 4C-seq reads are enriched with
telomeric repeats. Telomere content comparison was assessed by TelomereHunter
(Feuerbach et al., 2019). Illumina data was simulated using ART (Huang et al., 2012).
Reads were produced to cover the entire UCSC hg38 reference genome at 1X coverage.
Then, several simulated reads equivalent to the number of reads sequenced between
ciHHV-6A 4C-seq data were randomly sampled from the simulated data. TelomereHunter
was run on all samples and a non-parametric Wilcoxon test was performed to compare 4Cseq reads to simulated reads (p-value = 0.002).
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Appendix A-2: Supplemental Figure 2.2. HHV-6A trans interaction regions are
enriched with repressive histone modifications H3K9me3 and H3K27me3. A. Genome
tracks across chromosome 15 for ciHHV-6A showing significant 4C trans peak regions
(top track), 4C signal coverage, HEK293T H3K9me3 ChIP signal and HEK293T
137

H3K27me3 ChIP signal (bottom track). B. The same as A, but across chromosome 19 for
iciHHV-6A samples.
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Appendix A-3: Supplemental Figure 2.3. Similarities in chromatin state annotation
in tissues related to HEK293 cells. A. The significant trans regions returned by the 4C
window method were annotated using the 127 epigenomes chromHMM 25-state model as
in Figure 2D. B and C. Annotations for fetal kidney and fetal adrenal gland tissues were
then added for comparison with A.
Appendix A-4: Supplemental table 2.1. viewpoint primers designed for HHV-6A 4CSeq experiments presented in chapter 2.
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Appendix A-5: Supplemental table 2.2.1. 4C-Seq alignment mapping results to
human reference genome (UCSC Hg38).
Experi
ment

Virus
aligned

Cell

Viewp Sample
oint

Illumin
a 4C
ciHHV6A for
window
method
(trans
peaks)
Illumin
a 4C
ciHHV6A for
window
method
(trans
peaks)
Illumin
a 4C
ciHHV6A for
window
method
(trans
peaks)
Illumin
a 4C
ciHHV6A for
window
method
(trans
peaks)
Illumin
a 4C
iciHHV
-6A for
window
method

GFP

ciHHV
-6A
(HHV6AGFP
HEK2
93T)

vp1

33_S33_L002_R 5218
1_001
61

Percent
Mappe
d
614726 45.9147
43

GFP

ciHHV
-6A
(HHV6AGFP
HEK2
93T)

vp2

34_S34_L002_R 8710
1_001
36

541435 61.6675
3158

GFP

ciHHV
-6A
(HHV6AGFP
HEK2
93T)

vp1

35_S35_L002_R 6872
1_001
1

767298 8.22002
8492

GFP

ciHHV
-6A
(HHV6AGFP
HEK2
93T)

vp2

36_S36_L002_R 8211
1_001
3

681939 10.7470
4339

NC_001
664.4

iciHH
V-6A
(iciHH
V-6A+
SMC)

vp1

29_S29_L002_R 9249
1_001
3

83829

141

Map
ped

Unma
pped

52.4568
6868

(trans
peaks)
Illumin
a 4C
iciHHV
-6A for
window
method
(trans
peaks)
Illumin
a 4C
iciHHV
-6A for
window
method
(trans
peaks)
Illumin
a 4C
iciHHV
-6A for
window
method
(trans
peaks)
Illumin
a 4C
ciHHV6A for
peakC
(cis
peaks)
Illumin
a 4C
ciHHV6A for
peakC
(cis
peaks)
Illumin
a 4C
ciHHV6A for

NC_001
664.4

iciHH
V-6A
(iciHH
V-6A+
SMC)

vp2

30_S30_L002_R 2439
1_001
15

101992 70.5146
1809

NC_001
664.4

iciHH
V-6A
(iciHH
V-6A+
SMC)

vp1

31_S31_L002_R 9417
1_001
09

677226 58.1684
2554

NC_001
664.4

iciHH
V-6A
(iciHH
V-6A+
SMC)

vp2

32_S32_L002_R 5576
1_001
69

342514 61.9506
256

GFP

ciHHV
-6A
(HHV6AGFP
HEK2
93T)
ciHHV
-6A
(HHV6AGFP
HEK2
93T)
ciHHV
-6A
(HHV6A-

vp1

33_S33_L002_R 1097
1_001
794

38793

vp2

34_S34_L002_R 1297
1_001
841

114630 91.8844
3515

vp1

35_S35_L002_R 8043
1_001
74

31645

GFP

GFP

142

96.5868
8688

96.2147
9895

peakC
(cis
peaks)
Illumin
a 4C
ciHHV6A for
peakC
(cis
peaks)
Illumin
a 4C
iciHHV
-6A for
peakC
(cis
peaks)
Illumin
a 4C
iciHHV
-6A for
peakC
(cis
peaks)
Illumin
a 4C
iciHHV
-6A for
peakC
(cis
peaks)
Illumin
a 4C
iciHHV
-6A for
peakC
(cis
peaks)
ONP
titration
s

GFP

NC_001
664.4

GFP
HEK2
93T)
ciHHV
-6A
(HHV6AGFP
HEK2
93T)
iciHH
V-6A
(iciHH
V-6A+
SMC)

vp2

36_S36_L002_R 7381
1_001
57

25895

96.6108
3277

vp1

29_S29_L002_R 1325
1_001
06

43816

75.1500
0964

89.2118
4018

NC_001
664.4

iciHH
V-6A
(iciHH
V-6A+
SMC)

vp2

30_S30_L002_R 3085
1_001
90

37317

NC_001
664.4

iciHH
V-6A
(iciHH
V-6A+
SMC)

vp1

31_S31_L002_R 1098
1_001
379

520556 67.8457
7515

NC_001
664.4

iciHH
V-6A
(iciHH
V-6A+
SMC)

vp2

32_S32_L002_R 7014
1_001
51

198732 77.9231
5563

NC_001
664.4

iciHH
V-6A
(iciHH
V-6A+
SMC)

vp1

sample_6a_6_10 9782
e7_35X
5

46172

143

67.9354
431

ONP
titration
s

NC_001
664.4

ONP
titration
s

NC_001
664.4

ONP
titration
s

NC_001
664.4

ONP
titration
s

NC_001
664.4

ONP
titration
s

NC_001
664.4

ONP
titration
s

NC_001
664.4

ONP
titration
s

NC_001
664.4

ONP
titration
s

NC_001
664.4

ONP
titration
s

NC_001
664.4

iciHH
V-6A
(iciHH
V-6A+
SMC)
iciHH
V-6A
(iciHH
V-6A+
SMC)
iciHH
V-6A
(iciHH
V-6A+
SMC)
iciHH
V-6A
(iciHH
V-6A+
SMC)
iciHH
V-6A
(iciHH
V-6A+
SMC)
iciHH
V-6A
(iciHH
V-6A+
SMC)
iciHH
V-6A
(iciHH
V-6A+
SMC)
iciHH
V-6A
(iciHH
V-6A+
SMC)
iciHH
V-6A
(iciHH

vp1

sample_6a_6_10 1183
e7_25X
50

64174

64.8407
8806

vp1

sample_6a_6_10 2087
e6
6

18522

52.9874
6129

vp1

sample_6a_6_10 2447
e5
9

18294

57.2300
2829

vp1

sample_6a_6_10 1397
e4
0

10692

56.6458
5192

vp1

sample_6a_6_pb 7102
mc

3516

66.8864
1929

vp2

sample_6a_10_1 1433
0e7_35X
8

8905

61.6873
8975

vp2

sample_6a_10_1 4343
0e7_25X
8

27536

61.2026
9394

vp2

sample_6a_10_1 9044
0e6

7192

55.7033
7522

vp2

sample_6a_10_1 5723
0e5

2868

66.6162
2628

144

ONP
titration
s

NC_001
664.4

ONP
titration
s

NC_001
664.4

V-6A+
SMC)
iciHH
V-6A
(iciHH
V-6A+
SMC)
iciHH
V-6A
(iciHH
V-6A+
SMC)

vp2

sample_6a_10_1 2769
0e4

1295

68.1348
4252

vp2

sample_6a_10_p 4371
bmc

2360

64.9383
4497

Appendix A-6: Supplemental table 2.2.2. Identified significant cis interactions.
sample
bed.peakc.vp1.293
bed.peakc.vp1.293
bed.peakc.vp1.293
bed.peakc.vp1.293
bed.peakc.vp1.293
bed.peakc.vp2.293
bed.peakc.vp2.293
bed.peakc.vp2.293
bed.peakc.vp2.293
bed.peakc.vp2.293
bed.peakc.vp2.293
bed.peakc.vp2.293
bed.peakc.vp1.smc

cell
ciHHV-6A (HHV-6AGFP HEK293T)
ciHHV-6A (HHV-6AGFP HEK293T)
ciHHV-6A (HHV-6AGFP HEK293T)
ciHHV-6A (HHV-6AGFP HEK293T)
ciHHV-6A (HHV-6AGFP HEK293T)
ciHHV-6A (HHV-6AGFP HEK293T)
ciHHV-6A (HHV-6AGFP HEK293T)
ciHHV-6A (HHV-6AGFP HEK293T)
ciHHV-6A (HHV-6AGFP HEK293T)
ciHHV-6A (HHV-6AGFP HEK293T)
ciHHV-6A (HHV-6AGFP HEK293T)
ciHHV-6A (HHV-6AGFP HEK293T)
iciHHV-6A (iciHHV6A+ SMC)
145

viewp
chrom
oint
hhv6avp1
gfp
hhv6avp1
gfp
hhv6avp1
gfp
hhv6avp1
gfp
hhv6avp1
gfp
hhv6avp2
gfp
hhv6avp2
gfp
hhv6avp2
gfp
hhv6avp2
gfp
hhv6avp2
gfp
hhv6avp2
gfp
hhv6avp2
gfp
NC_001
vp1
664.4

chrom
Start

chrom
End

40483

40544

63477

63554

77596

77683

11208
1
13901
138929
2
112004

53292

53353

55502

55579

111993
117493
138993
144665
158849
19887

11208
4
11757
8
13901
3
14474
6
15887
6
19946

iciHHV-6A (iciHHV6A+ SMC)
iciHHV-6A (iciHHV6A+ SMC)
iciHHV-6A (iciHHV6A+ SMC)
iciHHV-6A (iciHHV6A+ SMC)
iciHHV-6A (iciHHV6A+ SMC)
iciHHV-6A (iciHHV6A+ SMC)
iciHHV-6A (iciHHV6A+ SMC)
iciHHV-6A (iciHHV6A+ SMC)
iciHHV-6A (iciHHV6A+ SMC)
iciHHV-6A (iciHHV6A+ SMC)
iciHHV-6A (iciHHV6A+ SMC)
iciHHV-6A (iciHHV6A+ SMC)
iciHHV-6A (iciHHV6A+ SMC)
iciHHV-6A (iciHHV6A+ SMC)
iciHHV-6A (iciHHV6A+ SMC)
iciHHV-6A (iciHHV6A+ SMC)
iciHHV-6A (iciHHV6A+ SMC)

bed.peakc.vp1.smc
bed.peakc.vp2.smc
bed.peakc.vp2.smc
bed.peakc.vp2.smc
bed.peakc.vp2.smc
bed.peakc.vp2.smc
bed.peakc.vp2.smc
bed.peakc.vp2.smc
bed.peakc.vp2.smc
bed.peakc.vp2.smc
bed.peakc.vp2.smc
bed.peakc.vp2.smc
bed.peakc.vp2.smc
bed.peakc.vp2.smc
bed.peakc.vp2.smc
bed.peakc.vp2.smc
bed.peakc.vp2.smc

vp1
vp2
vp2
vp2
vp2
vp2
vp2
vp2
vp2
vp2
vp2
vp2
vp2
vp2
vp2
vp2
vp2

NC_001
664.4
NC_001
664.4
NC_001
664.4
NC_001
664.4
NC_001
664.4
NC_001
664.4
NC_001
664.4
NC_001
664.4
NC_001
664.4
NC_001
664.4
NC_001
664.4
NC_001
664.4
NC_001
664.4
NC_001
664.4
NC_001
664.4
NC_001
664.4
NC_001
664.4

19887

19946

18299

18380

19951

20014

22304

22373

41338

41478

53323

53419

63528

63671

75356

75450

77651

77732

92097

92180

94690

94831

97662

97750

103725
108670
119614
124122
149965

10388
1
10875
7
11963
7
12427
3
15005
4

Appendix A-7: Supplemental table 2.2.3. Identified significant trans interactions.
sample

cell

viewpoi
nt

chrom

chromSta
rt

chromEn
d

illumina ciHHV6A vp1 rep1

ciHHV-6A
(HHV-6A-GFP
HEK293T)

vp1

chr15

98596798

98961988
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illumina ciHHV6A vp1 rep1
illumina ciHHV6A vp1 rep1
illumina ciHHV6A vp1 rep1
illumina ciHHV6A vp2 rep1
illumina ciHHV6A vp2 rep1
illumina ciHHV6A vp2 rep1
illumina iciHHV6A vp1 rep1
illumina iciHHV6A vp1 rep1
illumina iciHHV6A vp2 rep1
illumina iciHHV6A vp2 rep1
illumina iciHHV6A vp1 rep2
illumina iciHHV6A vp1 rep2
illumina iciHHV6A vp1 rep2
illumina iciHHV6A vp1 rep2

ciHHV-6A
(HHV-6A-GFP
HEK293T)
ciHHV-6A
(HHV-6A-GFP
HEK293T)
ciHHV-6A
(HHV-6A-GFP
HEK293T)
ciHHV-6A
(HHV-6A-GFP
HEK293T)
ciHHV-6A
(HHV-6A-GFP
HEK293T)
ciHHV-6A
(HHV-6A-GFP
HEK293T)
iciHHV-6A
(iciHHV-6A+
SMC)
iciHHV-6A
(iciHHV-6A+
SMC)
iciHHV-6A
(iciHHV-6A+
SMC)
iciHHV-6A
(iciHHV-6A+
SMC)
iciHHV-6A
(iciHHV-6A+
SMC)
iciHHV-6A
(iciHHV-6A+
SMC)
iciHHV-6A
(iciHHV-6A+
SMC)
iciHHV-6A
(iciHHV-6A+
SMC)

vp1

chr15

99920132

10025377
4

vp1

chr15

10109496
1

10194736
7

vp1

chr17

25870638

26110959

vp2

chr13

16986159

17402007

vp2

chr15

99812578

10015299
6

vp2

chr15

10112742
5

10194736
4

vp1

chr19

57954477

58297244

vp1

chr5

46491480

46786604

vp2

chr19

56650087

56887714

vp2

chr19

58073924

58583680

vp1

chr19

51751008

52140370

vp1

chr19

55751644

56222163

vp1

chr19

56336437

56889554

vp1

chr19

56999717

57734180
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iciHHV-6A
illumina iciHHV(iciHHV-6A+
6A vp1 rep2
SMC)
iciHHV-6A
illumina iciHHV(iciHHV-6A+
6A vp1 rep2
SMC)
iciHHV-6A
illumina iciHHV(iciHHV-6A+
6A vp2 rep2
SMC)
iciHHV-6A
illumina iciHHV(iciHHV-6A+
6A vp2 rep2
SMC)
iciHHV-6A
illumina iciHHV(iciHHV-6A+
6A vp2 rep2
SMC)

vp1

chr19

57840298

58583760

vp1

chr2

93383343

93662225

vp2

chr19

55875090

56282506

vp2

chr19

56399232

57787075

vp2

chr19

57920333

58591574

148

Appendix B-1: Supplemental figure 3.1. Identified significant cis interactions across
the VZV genome. The virus-virus (cis) three-dimensional interactions are visualized
above for each of the four viewpoints selected. There is overlap in the contact regions
across viewpoints. Regions that overlap between two (or more viewpoints) indicate regions
of the virus genome that are in physical proximity to one another in three-dimensional
space.
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Appendix B-2: Supplemental table 3.1. Number of high confidence 4C-Seq trans
peaks by chromosome (334 total).

chrom

peak count

chr12

28

chr1

24

chr11

21

chr17

20

chr2

20

chr3

19

chr5

19

chr10

16

chr6

16

chr20

15

chr15

14

chr7

14

chr8

14

chr9

14

chr16

13

chr14

12

chr13

11

chr19

10
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chr4

10

chr22

9

chr18

7

chr21

6

chrX

2

151

GLOSSARY

HHV(s)
HSV-1/2
VZV
EBV
HCMV
HHV-6A/B
iciHHV-6A

ciHHV-6A

HHV-7
KSHV
RNA-Seq
ChIP-Seq
MNase-Seq
ATAC-Seq
3C-Seq
4C-Seq
5C-Seq
Hi-C-Seq
Highthroughput
sequencing
Deepsequencing
Sequencing

Human Herpesvirus(es)
Herpes simplex 1/2 (HHV-1/2, Human alphaherpesvirus 1/2)
Varicella Zoster Virus (HHV-3, Human alphaherpesvirus 3)
Epstein Barr Virus (HHV-4, Human gammaherpesvirus 4)
Human cytomegalovirus (HHV-5, human betaherpesvirus 5)
Human herpesvirus 6A/B (Human betaherpesvirus 6A/B)
The inheritable germline integrated form of HHV-6A infection.
Patients will have a copy of the HHV-6A genome in every cell in their
body. Affects ~1% of the world population. Also refers to the cell
model presented in this work derived from umbilical artery SMC cells
of patients infected with iciHHV-6A.
Chromosomally integrated HHV-6A. HHV-6A infection requires
integration of its genome within the host cell genome to establish the
latent stage of its life cycle. Also refers to the in vitro-derived cell model
of HHV-6A infection presented in this work. This cell model harbors a
recombinant GFP-expressing HHV-6A virus under control of an hCMV
promoter. Reactivation of the latent virus can be achieved via
administration of the phorbol ester TPA to these cells.
Human herpesvirus 7 (Human betaherpesvirus 7)
Kaposi
sarcoma-associated herpesvirus (HHV-8,
Human
gammaherpesvirus 8)
RNA sequencing
Chromatin immunoprecipitation sequencing
Micrococcal nuclease digestion with deep sequencing
Assay for transposase-accessible chromatin using sequencing
Chromosome conformation capture sequencing
Chromosome conformation capture circular sequencing
Chromosome conformation capture carbon copy sequencing
Genome-wide chromatin conformation capture using deep sequencing
Synonymous herein with “sequencing”, “next-generation sequencing”,
and “deep-sequencing” (e.g., Illumina or Nanopore brand sequencing
platforms)
Synonymous herein with “sequencing”, “next-generation sequencing”,
and “high-throughput sequencing” (e.g., Illumina or Nanopore brand
sequencing platforms)
Generally, refers to sequencing by synthesis or long-read sequencing
technologies in this work. (e.g., Illumina or Nanopore brand sequencing
technologies)
152

